<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk - Glechner, A - 2023 | Cochrane Library</title> <meta content="Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk - Glechner, A - 2023 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009632.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk - Glechner, A - 2023 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009632.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD009632.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk" name="citation_title"/> <meta content="Anna Glechner" name="citation_author"/> <meta content="anna.glechner@donau-uni.ac.at" name="citation_author_email"/> <meta content="Gernot Wagner" name="citation_author"/> <meta content="Jerzy W Mitus" name="citation_author"/> <meta content="Birgit Teufer" name="citation_author"/> <meta content="IMC University of Applied Sciences Krems" name="citation_author_institution"/> <meta content="Irma Klerings" name="citation_author"/> <meta content="Nina BÃ¶ck" name="citation_author"/> <meta content="Dr. Robert Milla" name="citation_author_institution"/> <meta content="Ludwig Grillich" name="citation_author"/> <meta content="Dominik Berzaczy" name="citation_author"/> <meta content="Medical University Vienna/General Hospital AKH" name="citation_author_institution"/> <meta content="Thomas H Helbich" name="citation_author"/> <meta content="Medical University Vienna/General Hospital AKH" name="citation_author_institution"/> <meta content="Gerald Gartlehner" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="3" name="citation_issue"/> <meta content="10.1002/14651858.CD009632.pub3" name="citation_doi"/> <meta content="2023" name="citation_date"/> <meta content="2023/03/31" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009632.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009632.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009632.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="*Breast Neoplasms [diagnostic imaging]; Early Detection of Cancer; Mammography; Randomized Controlled Trials as Topic; *Ultrasonography, Mammary" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD009632.pub3&amp;doi=10.1002/14651858.CD009632.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="77cjsSG8";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD009632\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD009632\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","zh_HANT","ru","th","ms","fa","id","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD009632.pub3",title:"Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk",firstPublishedDate:"Mar 31, 2023 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Breast Cancer Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009632.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009632.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> EspaÃ±ol </option> <option class="content-language-option" data-languagecode="fa" value="fa"> ÙØ§Ø±Ø³Û </option> <option class="content-language-option" data-languagecode="fr" value="fr"> FranÃ§ais </option> <option class="content-language-option" data-languagecode="hi" value="hi"> à¤¹à¤¿à¤¨à¥à¤¦à¥ </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> æ¥æ¬èª </option> <option class="content-language-option" data-languagecode="ko" value="ko"> íêµ­ì´ </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> PortuguÃªs </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Ð ÑÑÑÐºÐ¸Ð¹ </option> <option class="content-language-option" data-languagecode="ro" value="ro"> RomÃ¢nÄ </option> <option class="content-language-option" data-languagecode="ta" value="ta"> à®¤à®®à®¿à®´à¯ </option> <option class="content-language-option" data-languagecode="th" value="th"> à¸ à¸²à¸©à¸²à¹à¸à¸¢ </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> ç¹é«ä¸­æ </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> ç®ä½ä¸­æ </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD009632.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD009632.pub3/full/es"> EspaÃ±ol </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009632.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD009632.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;ÚÚ©ÛØ¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;à¸à¸à¸à¸±à¸à¸¢à¹à¸­&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en tÃ©rminos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;Ø®ÙØ§ØµÙ Ø¨Ù Ø²Ø¨Ø§Ù Ø³Ø§Ø¯Ù&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;RÃ©sumÃ© simplifiÃ©&quot;},{&quot;language&quot;:&quot;id&quot;,&quot;title&quot;:&quot;Saripati tinjauan sistematik&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym jÄzykiem&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Ð ÐµÐ·ÑÐ¼Ðµ Ð½Ð° Ð¿ÑÐ¾ÑÑÐ¾Ð¼ ÑÐ·ÑÐºÐµ&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;à¸à¹à¹à¸­à¸ªà¸£à¸¸à¸à¸ à¸²à¸©à¸²à¸à¸£à¸£à¸¡à¸à¸²&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;æ·ºé¡¯ææçå£èªçµè«&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD009632.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD009632.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD009632.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD009632.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views:Â </span> <span>9499 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD009632.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-sec-0074"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-sec-0068"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/appendices#CD009632-sec-0079"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/supinfo/CD009632StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/supinfo/CD009632StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright Â© 2023 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk </h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Anna Glechner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0005">Gernot Wagner</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0006">Jerzy W Mitus</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0007">Birgit Teufer</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0008">Irma Klerings</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0009">Nina BÃ¶ck</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0010">Ludwig Grillich</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0011">Dominik Berzaczy</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0012">Thomas H Helbich</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information#CD009632-cr-0013">Gerald Gartlehner</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information/en#CD009632-sec-0098">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 31 March 2023 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD009632.pub3">https://doi.org/10.1002/14651858.CD009632.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD009632-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009632-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD009632-abs-0015">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009632-abs-0009">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009632-abs-0012">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/th#CD009632-abs-0006">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD009632-abs-0001" lang="en"> <section id="CD009632-sec-0001"> <h3 class="title" id="CD009632-sec-0001">Background</h3> <p>Screening mammography can detect breast cancer at an early stage. Supporters of adding ultrasonography to the screening regimen consider it a safe and inexpensive approach to reduce falseânegative rates during screening. However, those opposed to it argue that performing supplemental ultrasonography will also increase the rate of falseâpositive findings and can lead to unnecessary biopsies and treatments. </p> </section> <section id="CD009632-sec-0002"> <h3 class="title" id="CD009632-sec-0002">Objectives</h3> <p>To assess the comparative effectiveness and safety of mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening for women at average risk of breast cancer. </p> </section> <section id="CD009632-sec-0003"> <h3 class="title" id="CD009632-sec-0003">Search methods</h3> <p>We searched the Cochrane Breast Cancer Group's Specialised Register, CENTRAL, MEDLINE, Embase, the World Health Organization International Clinical Trials Registry Platform (WHO ICTRP), and ClinicalTrials.gov up until 3 May 2021. </p> </section> <section id="CD009632-sec-0004"> <h3 class="title" id="CD009632-sec-0004">Selection criteria</h3> <p>For efficacy and harms, we considered randomised controlled trials (RCTs) and controlled nonârandomised studies enrolling at least 500 women at average risk for breast cancer between the ages of 40 and 75. </p> <p>We also included studies where 80% of the population met our age and breast cancer risk inclusion criteria. </p> </section> <section id="CD009632-sec-0005"> <h3 class="title" id="CD009632-sec-0005">Data collection and analysis</h3> <p>Two review authors screened abstracts and full texts, assessed risk of bias, and applied the GRADE approach. We calculated the risk ratio (RR) with 95% confidence intervals (CI) based on available event rates. We conducted a randomâeffects metaâanalysis. </p> </section> <section id="CD009632-sec-0006"> <h3 class="title" id="CD009632-sec-0006">Main results</h3> <p>We included eight studies: one RCT, two prospective cohort studies, and five retrospective cohort studies, enrolling 209,207 women with a followâup duration from one to three years. The proportion of women with dense breasts ranged from 48% to 100%. Five studies used digital mammography; one study used breast tomosynthesis; and two studies used automated breast ultrasonography (ABUS) in addition to mammography screening. One study used digital mammography alone or in combination with breast tomosynthesis and ABUS or handheld ultrasonography. Six of the eight studies evaluated the rate of cancer cases detected after one screening round, whilst two studies screened women once, twice, or more. </p> <p>None of the studies assessed whether mammography screening in combination with ultrasonography led to lower mortality from breast cancer or allâcause mortality. High certainty evidence from one trial showed that screening with a combination of mammography and ultrasonography detects more breast cancer than mammography alone. The JâSTART (Japan Strategic Antiâcancer Randomised Trial), enrolling 72,717 asymptomatic women, had a low risk of bias and found that two additional breast cancers per 1000 women were detected over two years with one additional ultrasonography than with mammography alone (5 versus 3 per 1000; RR 1.54, 95% CI 1.22 to 1.94). Low certainty evidence showed that the percentage of invasive tumours was similar, with no statistically significant difference between the two groups (69.6% (128 of 184) versus 73.5% (86 of 117); RR 0.95, 95% CI 0.82 to 1.09). However, positive lymph node status was detected less frequently in women with invasive cancer who underwent mammography screening in combination with ultrasonography than in women who underwent mammography alone (18% (23 of 128) versus 34% (29 of 86); RR 0.53, 95% CI 0.33 to 0.86; moderate certainty evidence). Further, interval carcinomas occurred less frequently in the group screened by mammography and ultrasonography compared with mammography alone (5 versus 10 in 10,000 women; RR 0.50, 95% CI 0.29 to 0.89; 72,717 participants; high certainty evidence). Falseânegative results were less common when ultrasonography was used in addition to mammography than with mammography alone: 9% (18 of 202) versus 23% (35 of 152; RR 0.39, 95% CI 0.23 to 0.66; moderate certainty evidence). However, the number of falseâpositive results and necessary biopsies were higher in the group with additional ultrasonography screening. Amongst 1000 women who do not have cancer, 37 more received a falseâpositive result when they participated in screening with a combination of mammography and ultrasonography than with mammography alone (RR 1.43, 95% CI 1.37 to 1.50; high certainty evidence). Compared to mammography alone, for every 1000 women participating in screening with a combination of mammography and ultrasonography, 27 more women will have a biopsy (RR 2.49, 95% CI 2.28 to 2.72; high certainty evidence). Results from cohort studies with methodological limitations confirmed these findings. </p> <p>A secondary analysis of the JâSTART provided results from 19,213 women with dense and nonâdense breasts. In women with dense breasts, the combination of mammography and ultrasonography detected three more cancer cases (0 fewer to 7 more) per 1000 women screened than mammography alone (RR 1.65, 95% CI 1.0 to 2.72; 11,390 participants; high certainty evidence). A metaâanalysis of three cohort studies with data from 50,327 women with dense breasts supported this finding, showing that mammography and ultrasonography combined led to statistically significantly more diagnosed cancer cases compared to mammography alone (RR 1.78, 95% CI 1.23 to 2.56; 50,327 participants; moderate certainty evidence). For women with nonâdense breasts, the secondary analysis of the JâSTART study demonstrated that more cancer cases were detected when adding ultrasound to mammography screening compared to mammography alone (RR 1.93, 95% CI 1.01 to 3.68; 7823 participants; moderate certainty evidence), whilst two cohort studies with data from 40,636 women found no statistically significant difference between the two screening methods (RR 1.13, 95% CI 0.85 to 1.49; low certainty evidence). </p> </section> <section id="CD009632-sec-0007"> <h3 class="title" id="CD009632-sec-0007">Authors' conclusions</h3> <p>Based on one study in women at average risk of breast cancer, ultrasonography in addition to mammography leads to more screeningâdetected breast cancer cases. For women with dense breasts, cohort studies more in line with realâlife clinical practice confirmed this finding, whilst cohort studies for women with nonâdense breasts showed no statistically significant difference between the two screening interventions. </p> <p>However, the number of falseâpositive results and biopsy rates were higher in women receiving additional ultrasonography for breast cancer screening. None of the included studies analysed whether the higher number of screenâdetected cancers in the intervention group resulted in a lower mortality rate compared to mammography alone. Randomised controlled trials or prospective cohort studies with a longer observation period are needed to assess the effects of the two screening interventions on morbidity and mortality. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD009632-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD009632-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD009632-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD009632-abs-0016">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="full/fa#CD009632-abs-0010">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="full/fr#CD009632-abs-0013">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="full/id#CD009632-abs-0011">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="full/ms#CD009632-abs-0008">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD009632-abs-0014">Polski</a> </li> <li class="section-language"> <a class="" href="full/ru#CD009632-abs-0005">Ð ÑÑÑÐºÐ¸Ð¹</a> </li> <li class="section-language"> <a class="" href="full/th#CD009632-abs-0007">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD009632-abs-0004">ç¹é«ä¸­æ</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD009632-abs-0002" lang="en"> <h3>Mammography followed by ultrasonography compared to mammography alone for breast cancer screening in women at average risk of breast cancer </h3> <p><b>What is the issue?</b> </p> <p>We examined the evidence for and against adding ultrasonography screening to mammograms for women at average risk for breast cancer. </p> <p><b>Why is it important?</b> </p> <p>It is important to weigh the pros and cons of screening because the increased detection of tumours through screening does not necessarily mean that more women will be saved. Evidence shows that mammography in healthy women between the ages of 50 and 69 can detect breast cancer early and reduce the risk of dying from breast cancer. However, mammography is not a perfect tool to detect breast cancer and can miss tumours in some women, particularly those with dense breasts. In these women, the tumour is difficult to distinguish from normal breast tissue on the mammogram. For women with nonâdense breasts, ultrasonography is often routinely performed in addition to mammography to increase the sensitivity of screening. </p> <p><b>Gap in the evidence: no study examined the effect of additional ultrasonography screening on death</b> </p> <p>To determine whether routine screening with mammography and ultrasonography is beneficial, a study (ideally a randomised controlled trial (RCT), that is a study in which participants are randomly assigned to one of two or more treatment groups) comparing whether disease progression and death rates differ between methods is essential. None of the studies, which followed women for one to three years, lasted long enough to determine whether more cancer cases detected during screening with mammography and ultrasonography lead to reductions in disease and death. </p> <p><b>How many more cancers are detected by mammography screening with additional ultrasonography?</b> </p> <p>We found one RCT and seven cohort studies (a type of study in which groups of people are followed over time) that analysed whether the combination of mammography and ultrasonography is more effective than mammography alone for early detection of breast cancer in women at average risk of breast cancer with no symptoms. </p> <p>The methods of the RCT were sound, and the study represented the best evidence currently available. The study included 72,717 women at average risk for breast cancer, 58% of whom had dense breast tissue. After a twoâyear followâup, women screened once with a combination of mammography and ultrasonography had two more breast cancers detected per 1000 women compared with women screened with mammography (5.0 versus 3.2 per 1000 women screened). </p> <p><b>How effective is additional ultrasound screening in women with dense or nonâdense breasts?</b> </p> <p>A recent publication analysed a subgroup of the RCT of 19,213 women, and reported results separately for women with dense and nonâdense breasts. </p> <p>In women with dense breasts, three more breast cancers per 1000 women were detected with mammography and ultrasonography than with mammography alone. This finding was supported by realâworld evidence: the combined result of three cohort studies examining a total of 50,327 women with dense breasts found additional cancers in women with dense breasts when mammography screening was supplemented with ultrasonography. In women with nonâdense breasts, the results of two cohort studies with data from 40,636 women were not consistent with the RCT and found no significant difference in the proportion of cancer cases between the two screening methods. </p> <p><b>How many cancer cases were invasive and had lymph nodes involved?</b> </p> <p>In the RCT, 71% of all tumours identified at screening were classified as invasive, with no significant difference between the two groups. However, the result for the difference between the two groups was imprecise, and our confidence in the result is low. In women with invasive cancer found by mammography screening combined with ultrasonography, lymph nodes were affected in fewer cases than in the group screened by mammography alone (18% (23 of 128) versus 34% (29 of 86)). </p> <p><b>Interval cancer: cancer cases detected in the time between screening rounds</b> </p> <p>The RCT also showed that cancers that were not found during screening examinations (but were found in the time period between examinations) occurred less frequently when screening was performed with a combination of mammography and ultrasonography (5 versus 10 per 10,000) than when screening was performed with mammography alone. </p> <p><b>Falseâpositive and falseânegative rate</b> </p> <p>The rate of falseânegative results, indicating a negative result when cancer is present, was lower (9% versus 23%) when ultrasonography was performed in addition to mammography. However, the combination of mammography and ultrasound resulted in more falseâpositives than mammography alone in women without cancer: 123 versus 86 per 1000 women. Moreover, of 1000 women screened with a combination of mammography and ultrasonography, 27 more needed a biopsy than with mammography alone. </p> <p><b>How upâtoâdate is this review?</b> </p> <p>We searched for studies published up to May 2021.</p> <p><b>Conclusion</b> </p> <p>It is unclear whether or to what extent ultrasonography in addition to mammography screening can reduce the risk of dying from breast cancer therefore ultrasonography should not be used on a routine basis. For women to make an informed decision, we need to assess whether the few additional cancers that can be detected by ultrasonography actually result in a decrease in breast cancer disease and death. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD009632-sec-0074" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD009632-sec-0074"></div> <h3 class="title" id="CD009632-sec-0075">Implications for practice</h3> <section id="CD009632-sec-0075"> <p>Ultrasonography in combination with mammography screening detects more breast cancer cases than mammography alone. However, the proportion of falseâpositive results is up to 1.5 times higher than with mammography screening alone. These results were shown by a large, methodologically wellâperformed randomised controlled trial and confirmed by large cohort studies. </p> <p>However, no study has examined the benefit of adding ultrasonography in terms of saving lives or reducing the burden of disease compared with mammography alone. The majority of women undergoing breast cancer screening do not have dense breasts and are at average risk. Similarly, amongst women with dense breasts, the majority have a low risk of developing breast cancer. </p> <p>At present, no methodologically sound evidence is available justifying the routine use of ultrasonography as an adjunct screening tool in such a population. Even if only a small proportion of screened women will be recalled due to positive ultrasonography findings, the rate of falseâpositive results and unnecessary harm caused by subsequent investigations may be unacceptably high given the lack of evidence supporting a gain in health benefits. The US Preventive Services Task Force also concludes that it is not possible to infer from the studies published to date whether the cancers identified by supplemental screening result in improved clinical outcomes and how many of these represent cancers that would not otherwise have become clinically apparent. </p> </section> <h3 class="title" id="CD009632-sec-0076">Implications for research</h3> <section id="CD009632-sec-0076"> <p>The lack of evidence clearly indicates the need for wellâconducted, controlled studies with outcomes other than cancer detection rates. Ideally, a methodologically sound randomised controlled trial or wellâconducted cohort studies would assess the comparative benefits and risks of mammography alone versus mammography with adjunct ultrasonography in terms of morbidity, screeningârelated harms, and mortality, although the consideration of mortality would require a long followâup period. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD009632-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD009632-sec-0008"></div> <div class="table" id="CD009632-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening in mixed populations of women with dense and nonâdense breasts</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Mammography + ultrasound compared to mammography alone for breast cancer screening in mixed populations of women with dense and nonâdense breasts</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> breast cancer screeningÂ in women with dense and nonâdense breasts<br/><b>Setting:Â </b> screening<br/><b>Intervention:</b> mammography + ultrasoundÂ <br/><b>Comparison:</b> mammography alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes after 1â to 2âyear followâup</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with mammography alone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk difference with mammography + ultrasound</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breast cancer mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Insufficient </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>NR</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Insufficient </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>NR</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>72,717<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.54<br/>(1.22 to 1.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 more per 1000<br/>(1 to 3 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>83,469</p> <p>(2 cohort studies)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.35 (0.92 to 1.98)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 more per 1000<br/>(0 to 3 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental detection of invasive cancers: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>301<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/>(0.82 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of invasive cases out of all cancer cases detected by screening</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 fewer per 100<br/>(13 fewer to 7 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental detection of invasive cancers: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>571<br/>(2 cohort studies) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Very low <sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.95 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of invasive cases out of all cancer cases detected by screening</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 fewer per 100<br/>(4 fewer to 5 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Interval cancer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>72,717<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/>(0.29 to 0.89) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 per 10,000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 fewer per 10,000<br/>(7 fewer to 1 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lymph node status</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>214<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/>(0.33 to 0.86) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of positive lymph node staus among invasive cancer cases</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16 fewer per 100<br/>(23 to 5 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseâpositive rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>70,825<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.43<br/>(1.37 to 1.50) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseâpositive results amongst women with no cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 more per 1000<br/>(32 more to 43 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseânegative rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>354<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.39<br/>(0.23 to 0.66) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseânegative results amongst women with cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 fewer per 100<br/>(8 to 18 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rate of biopsies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>72,717<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.49<br/>(2.28 to 2.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27 more per 1000<br/>(23 more to 31 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).Â <br/><b>CI:</b> confidence interval; <b>NR:</b> not reported; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to risk of bias in the two retrospective cohort studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>): in both studies, additional ultrasonography was performed at the explicit request of a radiologist. In the study by Buchberger and colleagues, women with nonâdense breasts were specifically allocated to receive additional ultrasonography. In one of the two studies, no information was provided on familial or genetic breast cancer risk (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>).<br/><sup>2</sup>Result not statistically significant, downgraded due to imprecision.<br/><sup>3</sup>Downgraded due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009632-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Mammography + ultrasound compared to mammography alone for breast cancer screening (dense breasts)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> breast cancer screening in women at average risk with dense breasts </p> <p><b>Setting:</b> screening<br/><b>Intervention:</b> mammography + ultrasound<br/><b>Comparison:</b> mammography alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes after 1â to 2âyear followâup</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with mammography alone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk difference with mammography + ultrasound</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection in women with dense breasts: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,390<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.65<br/>(1.0 to 2.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 more per 1000<br/>(0 fewer to 7 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection in women with dense breasts: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>50,327<br/>(3 cohort studies) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.78<br/>(1.23 to 2.56) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 more per 1000<br/>(1 more to 5 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental detection of invasive cancers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>65<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.91<br/>(0.67 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of invasive cases out of all cancer cases detected by screening</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 fewer per 100<br/>(23 fewer to 16 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Interval cancer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,390<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.29<br/>(0.08 to 1.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 fewer per 1000<br/>(2 to 0 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseâpositive rate in women with dense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,312<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.76<br/>(1.58 to 1.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseâpositive results amongst women with no cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 more per 1000<br/>(48 more to 80 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseânegative rate in women with dense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>78<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.23<br/>(0.07 to 0.78) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseânegative results amongst women with cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 fewer per 100<br/>(7 to 27 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Biopsy rate in women with dense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,390<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.73<br/>(2.24 to 3.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39 more per 1000<br/>(28 more to 53 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to risk of bias in one of the three retrospective cohort studies (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>): additional ultrasonography was performed at the explicit request of a radiologist. No information was provided on familial or genetic breast cancer risk. <br/><sup>2</sup>Result not statistically significant, downgraded due to imprecision.<br/><sup>3</sup>Downgraded due to imprecision. </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD009632-tbl-0003"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Mammography + ultrasound compared to mammography alone for breast cancer screening (nonâdense breasts)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> breast cancer screening (nonâdense breasts) <br/><b>Setting:</b> screening<br/><b>Intervention:</b> mammography + ultrasound <br/><b>Comparison:</b> mammography alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes after 1â to 2âyear followâup</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with mammography alone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk difference with mammography + ultrasound</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection for women with nonâdense breasts: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7823<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.93<br/>(1.01 to 3.68) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 more per 1000<br/>(0 fewer to 10 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection for women with nonâdense breasts: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>40,636<br/>(2 cohort studies) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/>(0.85 to 1.49) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 more per 1000<br/>(1 fewer to 2 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Interval cancer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7823<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.22<br/>(0.05 to 1.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 fewer per 1000<br/>(0 to 2 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseâpositive rate in women with nonâdense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7771<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.36<br/>(1.18 to 1.56) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseâpositive results amongst women with no cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 more per 1000<br/>(15 to 45 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseânegative rate in women with nonâdense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.18<br/>(0.04 to 0.74) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseânegative results amongst women with cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 fewer per 100<br/>(10 to 38 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Biopsy rate in women with nonâdense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7823<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.58<br/>(1.96 to 3.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 more per 1000<br/>(17 to 42 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to imprecision: absolute risk reduction with wide confidence interval.<br/><sup>2</sup>Downgraded due to risk of bias in the two retrospective cohort studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>): in both studies, additional ultrasonography was performed at the explicit request of a radiologist. In the study by Buchberger and colleagues, women with nonâdense breasts were specifically allocated to receive additional ultrasonography. In one of the two studies, no information was provided on familial or genetic breast cancer risk (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD009632-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD009632-sec-0009"></div> <section id="CD009632-sec-0010"> <h3 class="title" id="CD009632-sec-0010">Description of the condition</h3> <p>Breast cancer is the most common malignant disease diagnosed in women worldwide, comprising 24.5% of all female cancers in 2020 (<a href="./references#CD009632-bbs2-0071" title="SungH , FerlayJ , SiegelRL , LaversanneM , SoerjomataramI , JemalA , BrayF . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin2021;71(3):209-249.">Sung 2021</a>). The risk of developing breast cancer increases with age and with certain risk factors, such as dense breasts, a family history of breast or ovarian cancer, and familial breast cancer gene mutations of BRCA1 (BReast CAncer 1, early onset) and BRCA2 (BReast CAncer 2, susceptibility protein). According to the Surveillance, Epidemiology, and End Results (SEER) Cancer Statistics Review 2014 to 2018, the rate of new cases of female breast cancer was 129 per 100,000 women per year, and 20 per 100,000 women died per year (<a href="./references#CD009632-bbs2-0066" title="National Cancer Institute. SEER Cancer Statistics Review (CSR) 1975-2016. https://seer.cancer.gov/statfacts/html/breast.html accessed 2021.">SEER Cancer Statistics</a>). During their lifetime, 12.9% of women will be diagnosed with breast cancer. </p> <p>Screening with mammography can detect breast cancer at an early stage. Subsequent effective diagnostic pathways and treatment regimens can reduce the burden of breast cancer, most importantly the mortality in women aged 50 to 69 years (<a href="./references#CD009632-bbs2-0063" title="NelsonHD , FuR , CantorA , PappasM , DaegesM , HumphreyL . Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation. Annals of Internal Medicine2016;164(4):244-55.">Nelson 2016a</a>). A Cochrane Review estimated a relative reduction of mortality from breast cancer of 15%, corresponding to an absolute risk reduction of 0.05% in women aged 50 and older (<a href="./references#CD009632-bbs2-0053" title="GÃ¸tzschePC , JÃ¸rgensenKJ . Screening for breast cancer with mammography. Cochrane Database of Systematic Reviews2013, Issue 4. Art. No: CD001877. [DOI: 10.1002/14651858.CD001877.pub5]">GÃ¸tzsche 2013</a>). The sensitivity of mammography ranges between 77% and 95%, and the specificity ranges between 94% and 97% (<a href="./references#CD009632-bbs2-0062" title="NelsonHD , TyneK , NaikA , BougatsosC , ChanBK , HumphreyL , US Preventive Services Task Force. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Annals of Internal Medicine2009;151(10):727-37, W237-42.">Nelson 2009</a>). The diagnostic accuracy of mammography screening largely depends on the radiographic density of the imaged breasts (<a href="./references#CD009632-bbs2-0042" title="CarneyPA , MigliorettiDL , YankaskasBC , KerlikowskeK , RosenbergR , RutterCM . Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Annals of Internal Medicine2003;138(3):168-75.">Carney 2003</a>). In radiographically dense breasts, nonâcalcified breast cancers are more likely to be missed than in fatty breasts. Consequently, some cancers are not detected by mammography screening. </p> <p>Ultrasonography of the breast is currently not recommended in the screening of women at average risk for breast cancer (<a href="./references#CD009632-bbs2-0043" title="Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in women aged 40â74 years who are not at increased risk for breast cancer. Canadian Medical Association Journal2018;190:E1441-51.">CTFPHC 2018</a>; <a href="./references#CD009632-bbs2-0067" title="SiuAL . Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine2016;164(4):279-96.">Siu 2016</a>). Most clinical practice guidelines specify ultrasonography of the breast as a supplementary examination for further clarification of ambiguous findings (<a href="./references#CD009632-bbs2-0036" title="AlbertUS , AltlandH , DudaV , EngelJ , GeraedtsM , Heywang-KobrunnerS . 2008 update of the guideline: early detection of breast cancer in Germany. Journal of Cancer Research and Clinical Oncology2009;135(3):339-54.">Albert 2009</a>). The European Guidelines on Quality Assurance in Breast Cancer Screening and Diagnosis do not recommend tailored screening with automated or handheld breast ultrasound in asymptomatic women with high mammographic breast density (<a href="./references#CD009632-bbs2-0049" title="Women with high breast density. https://healthcare-quality.jrc.ec.europa.eu/european-breast-cancer-guidelines/dense-breast 3 August 2021.">European Comission 2021</a>)<i>.</i> </p> <p>Supporters of supplemental ultrasonography to the screening regimen for breast cancer argue that it might be a safe and inexpensive approach to reduce the falseânegative rates of the screening process. However, those opposed are concerned that performing supplemental ultrasonography on women at average risk will also increase the rate of falseâpositive findings and can lead to unnecessary biopsies and treatments. Authors of a 2016 systematic review of six observational studies in ultrasonography noted the increased biopsy rate in women with dense breasts and negative mammography who underwent an additional ultrasonography, finding a positive predictive value ranging from 3.0% to 8.3%, meaning that over 90% of positively classified findings were falseâpositive (<a href="./references#CD009632-bbs2-0060" title="MelnikowJ , FentonJJ , WhitlockEP . Supplemental screening for breast cancer in women with dense breasts: a systematic review for the U.S. Preventive Service Task Force. Agency for Healthcare Research and Quality (US). Vol. Evidence Syntheses, No. 126. Available from: https://www.ncbi.nlm.nih.gov/books/NBK343793/: U.S. Preventive Services Task Force, 2016.">Melnikow 2016</a>). </p> </section> <section id="CD009632-sec-0011"> <h3 class="title" id="CD009632-sec-0011">Description of the intervention</h3> <p>The intervention entails any form of mammography screening (e.g. one view, two views, digital, etc.) with adjunct breast ultrasonography used as a simultaneous screening test. We excluded studies that only included women with negative mammographies because in such a population it would not be possible to compare the efficacy of combining ultrasonography and mammography screening with mammography screening alone. Breast ultrasonography as a diagnostic test following a positive mammogram was not of interest for this systematic review. </p> <p>To assess the rate of falseâpositives, studies that used biopsy as a reference standard were accepted. </p> </section> <section id="CD009632-sec-0012"> <h3 class="title" id="CD009632-sec-0012">How the intervention might work</h3> <p>To increase either sensitivity or specificity, two or more screening tests may be applied in the same individuals. These tests can be used sequentially or simultaneously. Sequential screening tests are applied in a proportion of the population with a specific result of the first screening test. In sequential screening, the postâtest probability of the first screening test becomes the preâtest probability of the second screening test. The goal of sequential screening is usually to increase sensitivity. By contrast, simultaneous screening applies two (or more) tests to the screened individuals without knowledge of the results of each individual test. The preâtest probability therefore remains the same for all tests. Because we wanted to evaluate the efficacy of routine breast ultrasonography in addition to mammography screening, we excluded studies that examined only women with a negative mammography result because of the lower yield of cancers detected by ultrasonography after a negative mammogram, resulting in a high number of falseâpositives. </p> <p>Breast ultrasonography is used routinely as a diagnostic measure to distinguish benign from malignant lesions because it can differentiate between cysts and solid tumours and thus lowers the number of indeterminate mammographical findings. A 2015 study found that adding automated breast ultrasonography to screening mammography in a population that included an undefined proportion of women at higher risk for breast cancer resulted in an additional detection of 1.9 cancers per 1000 women screened (95% confidence interval 1.2 to 2.7; P &lt; 0.001) (<a href="./references#CD009632-bbs2-0041" title="BremRF , TabÃ¡rL , DuffySW , InciardiMF , GuingrichJA , HashimotoBE , et al. Assessing improvement in detection of breast cancer with three-dimensional automated breast US in women with dense breast tissue: the SomoInsight Study. Radiology2015;274(3):663-73.">Brem 2015</a>). Breast ultrasonography as an adjunct screening tool to mammography might therefore also be able to detect cancer lesions that mammography screening misses in a population at average risk of breast cancer. </p> <p>In women at increased risk for breast cancer, defined by high breast density or other risk factors, several studies have demonstrated that supplemental screening with ultrasonography can increase the detection rates of cancer, particularly in women with dense breasts (<a href="./references#CD009632-bbs2-0038" title="BergWA , BlumeJD , CormackJB , MendelsonEB , LehrerD , BÃ¶hm-VÃ©lezM , et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA2008;299(18):2151-63.">Berg 2008</a>; <a href="./references#CD009632-bbs2-0039" title="BergWA , ZhangZ , LehrerD , JongRA , PisanoED , BarrRG , et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA2012;307(13):1394-404.">Berg 2012</a>). On mammography, dense breast tissue results in the potential for underlying cancerous and small lesions to be obscured and is an independent risk factor for breast cancer. It is associated with a high risk of interval cancers, that is cancers that become clinically apparent between screening tests (<a href="./references#CD009632-bbs2-0061" title="MoshinaN , SebuÃ¸degÃ¥rdD , LeeCI , AkslenLA , TsurudaKM , ElmoreJG , et al. Automated volumetric analysis of mammographic density in a screening setting: worse outcomes for women with dense breasts. Radiology2018;288(2):343-52.">Moshina 2018</a>). Ultrasonography therefore has the potential to detect mammographically occult cancers at an earlier stage and to improve surrogate outcomes such as tumour size and lymph node status, which have been linked to a poor prognosis of breast cancer (<a href="./references#CD009632-bbs2-0068" title="SopikV , NarodSA . The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer. Breast Cancer Research and Treatment2018;170(3):647-56.">Sopik 2018</a>). </p> </section> <section id="CD009632-sec-0013"> <h3 class="title" id="CD009632-sec-0013">Why it is important to do this review</h3> <p>In women with increased risk for breast cancer, adjunct ultrasonography can improve the diagnostic yield of breast cancer screening (<a href="./references#CD009632-bbs2-0039" title="BergWA , ZhangZ , LehrerD , JongRA , PisanoED , BarrRG , et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA2012;307(13):1394-404.">Berg 2012</a>). Based on these findings, ultrasonography is sometimes used routinely as an adjunct screening tool in women at average risk. It is unclear whether the use of ultrasonography as an adjunct screening tool in women at average risk corresponds to a reduction in mortality and morbidity (the ultimate goal of any screening programme) or to an increase in screeningârelated harms. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD009632-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD009632-sec-0014"></div> <p>To assess the comparative effectiveness and safety of mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening for women at average risk of breast cancer. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD009632-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD009632-sec-0015"></div> <section id="CD009632-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD009632-sec-0017"> <h4 class="title">Types of studies</h4> <p>For efficacy and harms we considered randomised controlled trials (RCTs) with either individual or cluster randomisation and any controlled nonârandomised studies with a sample size of at least 500 participants. The only RCT from Japan considered women aged 40 to 49, so for both efficacy and safety, we included cohort studies that considered women up to age 75, for whom international screening recommendations are available due to higher tumour incidence. </p> <p>We included studies with a followâup period of at least one year and that included at least one relevant outcome. </p> </section> <section id="CD009632-sec-0018"> <h4 class="title">Types of participants</h4> <p>Women between the ages of 40 and 75 years who are at average risk for breast cancer, have not previously had breast cancer, and who participate in a breast cancer screening programme or undergo mammography screening. </p> <p>We define women at average risk as those who have a lifetime risk of less than 15% or who have dense breasts without any additional risk factors for breast cancer. </p> <p>We also accepted studies in which 80% of the population matched our age and breast cancer risk inclusion criteria. </p> </section> <section id="CD009632-sec-0019"> <h4 class="title">Types of interventions</h4> <p>Any form of mammography screening (e.g. one view, two views, digital, tomosynthesis (threeâdimensional (3D)âmammography), combination of 2Dâ and 3Dâmammography, etc.) with additional breast ultrasonography compared with mammography screening without breast ultrasonography. </p> <p>Studies that used biopsy as a reference standard were accepted in order to assess the rate of falseâpositives and falseânegatives. </p> <p><a href="#CD009632-fig-0001">Figure 1</a> depicts the analytic pathway of the research question. </p> <div class="figure" id="CD009632-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Analytic pathway of the comparative efficacy and risk of harms of mammography screening with and without supplemental ultrasonography." data-id="CD009632-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-01.jpg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Analytic pathway of the comparative efficacy and risk of harms of mammography screening with and without supplemental ultrasonography. </p> </div> </div> </div> </section> <section id="CD009632-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD009632-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD009632-list-0001"> <li> <p>Breast cancer mortality</p> </li> </ul> </p> </section> <section id="CD009632-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD009632-list-0002"> <li> <p>Allâcause mortality</p> </li> <li> <p>Incremental cancer detection</p> </li> <li> <p>Incremental detection of invasive cancers</p> </li> <li> <p>Interval cancer</p> </li> <li> <p>Lymph node status</p> </li> <li> <p>Size of detected cancers</p> </li> <li> <p>Healthârelated quality of life</p> </li> <li> <p>Falseâpositive rate</p> </li> <li> <p>Falseânegative rate</p> </li> <li> <p>Rate of biopsies</p> </li> <li> <p>Screeningâassociated harm (psychological distress, adverse effects caused by subsequent diagnostic or therapeutic interventions, others) </p> </li> </ul> </p> </section> </section> </section> <section id="CD009632-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD009632-sec-0024"> <h4 class="title">Electronic searches</h4> <p>For this 2021 review update, we reassessed the contribution of databases and other resources previously used and removed unnecessary databases and other resources and revised the search strategies. Specifically, for the MEDLINE search strategy, we combined two study design filters: a modified version of the Health Information Research Unit's Therapy filter (Ovid version, best balance of sensitivity and specificity) to identify RCTs (<a href="./references#CD009632-bbs2-0056" title="Health Information Research Unit. Search Filters for MEDLINE in Ovid Syntax and the PubMed translation. https://hiru.mcmaster.ca/hiru/HIRU_Hedges_MEDLINE_Strategies.aspx accessed 01 May 2021.">HIRU</a>), and a filter for controlled nonârandomised studies byÂ <a href="./references#CD009632-bbs2-0074" title="WaffenschmidtS , NavarroâRuanT , HobsonN , HausnerE , SauerlandS , HaynesRB . Development and validation of study filters for identifying controlled nonârandomized studies in PubMed and Ovid MEDLINE. Research Synthesis Methods2020;11(5):617-26.">Waffenschmidt 2020</a>Â (Ovid version, the best sensitivity). Additionally, to account for a new technology that had not been included in previous searches, we included new terms for digital breast tomosynthesis in the search strategies.Â  </p> <p>The new search strategies were designed by our team's information specialist (IK), and peer reviewed by the Cochrane Breast Cancer Group's Information Specialist, prior to the update search being conducted in May 2021.Â  </p> <p>We searched the following databases:</p> <p> <ul id="CD009632-list-0003"> <li> <p>Cochrane Breast Cancer Group (CBCG) Specialised Register, from 2011 to 10 May 2021;</p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL), from 2011 to Issue 4 of 12, April 2021 (Cochrane Library/Wiley) on 4 May 2021; </p> </li> <li> <p>Ovid MEDLINE(R) ALL from 2011 to 3 May 2021;</p> </li> <li> <p>Embase.com (Elsevier) from 2011 to 3 May 2021.</p> </li> </ul> </p> <p>We searched the CBCG Specialised Register on 10 May 2021 using the keywords 'mammography', 'tomosynthesis', 'ultrasonography', and 'screening'. Details of the searched databases and search strategies used by the CBCG Group for the identification of studies and the procedure used to code references are outlined in the CBCG Group's moduleÂ at breastcancer.cochrane.org/specialisedâregister. </p> <p>We limited all searches to publication dates since 2011 and applied no language restrictions. The search dates overlap with the search strategies of the previous review to account for the new technology of digital breast tomosynthesis, which had not been included in the previous search.Â  </p> <p>Full search strategies are reported inÂ <a href="./appendices#CD009632-sec-0080">Appendix 1</a>. </p> <p>Previous search strategies are reported inÂ <a href="./appendices#CD009632-sec-0084">Appendix 2</a>Â andÂ <a href="./appendices#CD009632-sec-0091">Appendix 3</a>. </p> </section> <section id="CD009632-sec-0025"> <h4 class="title">Searching other resources</h4> <p>We manually searched the reference lists of all included studies, pertinent reviews, and background articles on this topic to look for any relevant citations that our searches might have missed. </p> <p>We searched two clinical trial registries through 4 May 2021 (see <a href="./appendices#CD009632-sec-0080">Appendix 1</a> for search strategies): </p> <p> <ul id="CD009632-list-0004"> <li> <p>ClinicalTrials.gov (<a href="https://clinicaltrials.gov/" target="_blank">clinicaltrials.gov/</a>); </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (WHO ICTRP) (<a href="https://trialsearch.who.int/Default.aspx" target="_blank">trialsearch.who.it</a>). </p> </li> </ul> </p> </section> </section> <section id="CD009632-sec-0026"> <h3 class="title" id="CD009632-sec-0026">Data collection and analysis</h3> <section id="CD009632-sec-0027"> <h4 class="title">Selection of studies</h4> <p>We developed and pilotâtested literature review forms for abstract and fullâtext reviews. For the updated review, each abstract was independently reviewed by two authors on the team (Team: AG, JM, GW, GG, IK, DB, BT, NB, LG). We retrieved fullâtext copies of all studies that potentially met the inclusion criteria based on review of the abstract. Studies marked for possible inclusion by either review author underwent fullâtext review. In the case of insufficient information to determine inclusion or exclusion, we retrieved the full text of the study and then made the determination. If the needed information in the fullâtext article was unclear or missing, we contacted the study authors. Two trained members of the research team independently reviewed each fullâtext article for inclusion or exclusion based on the eligibility criteria described above. If both review authors agreed that a study did not meet the eligibility criteria, it was excluded. If the review authors disagreed, they resolved conflicts by discussion and consensus or by consulting a third member of the review team. All results were tracked in an EndNote 20 database (<a href="./references#CD009632-bbs2-0047" title="EndNote. Version 20.1. Clarivate, 30 October 2020. https://endnote.com.">EndNote 20</a>). </p> </section> <section id="CD009632-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>We designed, pilotâtested, and used structured data extraction forms to gather pertinent information from relevant articles; this included characteristics of study populations, settings, interventions, comparators, study designs, methods, and results. Trained review authors collected data from each study. A senior review author checked the data for accuracy. </p> </section> <section id="CD009632-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias, with a third review author consulted in case of disagreement. The aim of our review in relation to RCTs and nonârandomised studies was to assess the effect of assignment to interventions at baseline. To assess the risk of bias in included randomised trials, we used the Cochrane risk of bias tool (RoB 2) as described by the Cochrane Methods Network (<a href="./references#CD009632-bbs2-0070" title="SterneJAC , SavoviÄJ , PageMJ , ElbersRG , BlencoweNS , BoutronI , et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ2019;366:I4898.">Sterne 2019</a>), using a standardised data abstraction form. Outcomes assessed in each study using RoB 2 are listed in <a href="#CD009632-tbl-0004">Table 1</a>. This tool includes the following domains: randomisation process, deviations from intended interventions, missing data, measurement of the outcomes, and selection of the reported results. RoB 2 includes algorithms with signalling questions for each domain, with the following choices for risk of bias assessment: (1) low risk of bias; (2) some concerns; and (3) high risk of bias. </p> <div class="table" id="CD009632-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Risk of bias for randomised controlled trial (JâSTART): all outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias arising from the randomisation process</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to missing outcome data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to selection of the reported result</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incremental cancer detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incremental detection of invasive cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interval cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lymph node status</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Falseânegative rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Falseâpositive rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate of biopsies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Justification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomisation was performed centrally by an independent research unit. Allocation codes were kept in sealed envelopes and sent to the principal investigator. Baseline characteristics were similarly distributed between the two groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incomplete blinding: because of the nature of the two screening methods, it was not possible to mask participants and study coâordinators. To minimise bias, an independent panel unaware of the group assignment performed outcome assessment. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>During the course of the study, 0.4% of the initially 72,998 women dropped out at baseline, or data were missing or unknown. The rate of dropouts and missing data was similar in both study groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unlikely that the detection of cancer cases, usually confirmed by biopsy, in the respective group was influenced by incomplete blinding. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The reported endpoints were published in advance in a study protocol.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> </div> <p>For nonârandomised studies, we assessed risk of bias using the ROBINSâI tool (<a href="./references#CD009632-bbs2-0069" title="SterneJA , HernÃ¡nMA , ReevesBC , SavoviÄJ , BerkmanND , ViswanathanM , et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:i4919.">Sterne 2016</a>). Outcomes assessed in each study using ROBINSâI are listed in the Additional tables. This tool includes the following domains: bias due to confounding, participant selection for the study, classification of intervention, deviations from intended interventions, missing data, measurement of outcomes, and selection of reported results. Confounding could be caused by an unbalanced distribution of prognostic factors between the groups being compared or by reporting results from two or more rounds of screening, as the preâtest probability of detecting cancer in the second round is lower if the test result is negative after the first round of screening. ROBINSâI includes algorithms with signalling questions for each domain, with the following choices for bias risk assessment: (1) low risk of bias; (2) moderate risk of bias; (3) serious risk of bias; and (4) critical risk of bias. We used a standardised data abstraction form to implement ROBINSâI and assess all relevant domains. </p> </section> <section id="CD009632-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We extracted data from the original studies to construct 2 x 2 tables. Where multiple studies allowed for quantitative analysis, we calculated the risk ratio (RR) with 95% confidence intervals (CIs) for each outcome using RevMan Web (<a href="./references#CD009632-bbs2-0065" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>). </p> </section> <section id="CD009632-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was women (not cancer lesions).</p> </section> <section id="CD009632-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We used a modified intentionâtoâtreat analysis where data were missing from participants who dropped out of trials before completion. Where data regarding an outcome of interest were not reported, we contacted the study authors to obtain the missing results. </p> </section> <section id="CD009632-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We used the Cochrane Chi<sup>2</sup> test (Qâtest) to assess heterogeneity of metaâanalyses. We also used the I<sup>2</sup> statistic to estimate the degree of heterogeneity. This measure describes the percentage of total variation across studies that results from heterogeneity rather than chance. We interpreted the importance of any heterogeneity in terms of its magnitude and the direction of effects. We did not use thresholds; instead we adopted the overlapping bands suggested in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i>. For example, we considered an I<sup>2</sup> of 0% to 40% as probably not important, 30% to 60% as representing moderate heterogeneity, 50% to 90% as substantial heterogeneity, and 75% to 100% as considerable heterogeneity (<a href="./references#CD009632-bbs2-0055" title="HigginsJPT , ThomasJ . Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019) The Cochrane Collaboration, 2019. Available from training.cochrane.org/handbook/archive/v6.">Higgins 2019</a>). The result of the Chi<sup>2</sup> test is included in the forest plots. </p> </section> <section id="CD009632-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>We checked trial registries (e.g. ClinicalTrials.gov and WHO ICTRP) to identify completed but unpublished trials. </p> <p>Due to the small number of studies on breast cancer screening with mammography in combination with breast ultrasound compared with mammography alone, the power of statistical methods to explore publication bias, such as funnel plots, is limited. Because of the low sensitivity to detect publication bias, we did not present funnel plots. </p> </section> <section id="CD009632-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We analysed the data using RevMan Web (<a href="./references#CD009632-bbs2-0065" title="Review Manager Web (RevMan Web). Version 4.12.0. The Cochrane Collaboration, 2022. Available at revman.cochrane.org.">RevMan Web 2022</a>). We pooled data for metaâanalysis where the participant groups were similar and the studies assessed the same treatments with the same comparator and had similar definitions of outcome measures over a similar duration of treatment. The included studies reported unadjusted data. We therefore focused on whether the intervention groups were comparable in terms of breast cancer risk and described whether confounding factors were adequately accounted for in the cohort studies. We used a randomâeffects model. We rated the strength of the evidence based on the system developed by the GRADE Working Group. </p> </section> <section id="CD009632-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We presented separate results based on breast density. We performed analyses separately for women with dense and nonâdense breasts for the following outcomes: incremental cancer detection rate, incremental invasive cancer detection, interval cancer, lymph node status, falseâpositive rate, falseânegative rate, and biopsy rate. We did not present a subgroup analysis, as according to <i>Cochrane Handbook</i> guidelines at least 10 observations should be available for each characteristic modelled. </p> </section> <section id="CD009632-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>When studies at high risk of bias contributed to the evidence, we presented results separately. Separate results associated with a high risk of bias were presented for incremental cancer detection rate in women with mixed populations with dense and nonâdense breasts and for women with dense breasts. In addition, results of the high risk of bias studies were presented for the incremental detection rate of invasive cancer and interval cancer in women with dense breasts. </p> </section> <section id="CD009632-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We used the GRADE system to evaluate the certainty of evidence regarding the comparative effectiveness of screening methods in reducing mortality due to breast cancer or allâcause mortality, detecting incremental breast cancer and incident interval cancer cases, and determining lymph node status, falseâpositive rate, falseânegative rate, and biopsy rate. GRADE criteria for assessing the certainty of the evidence include study limitations, inconsistency of results, indirectness of evidence, imprecision, and publication bias (<a href="./references#CD009632-bbs2-0037" title="BalshemH , HelfandM , SchÃ¼nemannHJ , OxmanAD , KunzR , BrozekJ , et al. GRADE guidelines: 3. Rating the quality of evidence. Journal of Clinical Epidemiology2011;64(4):401-6.">Balshem 2011</a>). </p> <p>The GRADE assessment includes four categories: high, moderate, low, and very low certainty evidence. We used GRADEpro GDT to summarise the main findings and to assess the certainty of the evidence (<a href="./references#CD009632-bbs2-0052" title="GRADEpro GDT. Version accessed 30 November 2022. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). Results of cohort studies were presented separately in the summary of findings tables. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD009632-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD009632-sec-0039"></div> <section id="CD009632-sec-0040"> <h3 class="title">Description of studies</h3> <section id="CD009632-sec-0041"> <h4 class="title">Results of the search</h4> <p>For the current update of the review, we identified 2164 unique citations from searches and reviews of reference lists. We retrieved 37 fullâtext articles for detailed examination. A total of eight studies published in 10 articles (one RCT, <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, with secondary analysis of the RCT; two prospective studies (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>); and five retrospective studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>; <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>)) met our eligibility criteria. The search results and the flow of the literature for this report are shown in <a href="#CD009632-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD009632-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD009632-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>In the original review, we identified one ongoing RCT (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>), which has since become an included study. </p> </section> <section id="CD009632-sec-0042"> <h4 class="title">Included studies</h4> <p>One RCT, <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, with a secondary analysis in 2021, two prospective studies, <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>, and five retrospective cohort studies, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>; <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>, with data of altogether 209,207 women assessed the comparative efficacy of mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening. The JâSTART, an RCT including 72,717 women, provided the best evidence (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>). In a secondary analysis of a subpopulation of the JâSTART which included 19,213 women, the results of women with dense and nonâdense breasts were presented separately. Six of the eight studies assessed the sensitivity and specificity of the two screening methods during one screening round. In these studies, a second screening round, if performed, served to detect interval cancers. In the prospective cohort study by <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a> and the retrospective study by <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>, women participated in one, two, or more screening rounds (not specified). The results of the two studies that had screened women more than once are presented separately. </p> <section id="CD009632-sec-0043"> <h5 class="title">Participants</h5> <p>Participants in the RCT, <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, were younger than women included in the cohort studies. In JâSTART, ages ranged from 40 to 49, whilst in the cohort studies, the majority of women were between 40 and 70 years old. All studies examined data from asymptomatic women who had undergone breast cancer screening. Six of the eight studies included populations without a personal history of breast cancer; two studies lacked precise population information (<a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>); and one study did not report the percentage of women with a firstâdegree relative who had had breast cancer (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). In the JâSTART study, 95.3% of women had no firstâdegree relative with breast cancer, 4.6% had one, and 0.1% had more than one firstâdegree relative affected by breast cancer (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>). In JâSTART, 1.3% women had had a benign neoplasm in the past, 2% had breast surgery, and 0.7% had ever had breast inflammation. In the largest retrospective cohort study by Buchberger and colleagues (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>), women with a personal or family history of breast cancer were excluded, whilst in the secondâlargest retrospective study by Lee and colleagues (<a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>), 13% of the screening examinations were performed on women who had a fiveâyear breast cancer risk of 2.5% to 3.99%, and 2% on women with a fiveâyear risk of 3.99% or higher. </p> <p>The proportion of women with dense breasts in the included studies ranged from 48% to 100%. Three cohort studies were performed exclusively in women with dense breasts (<a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>), and three studies presented separate data for women with dense and nonâdense breasts (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). </p> </section> <section id="CD009632-sec-0044"> <h5 class="title">Interventions</h5> <p>Five studies used digital mammography (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>); one study used breast tomosynthesis (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>); and two studies used automated breast ultrasound (ABUS) in addition to mammography (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>). One study used either digital mammography alone or in combination with tomosynthesis, and women who were referred to receive additional ultrasonography were examined with ABUS (oneâthird) or handheld ultrasonography (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). The secondâlargest retrospective study lacked information on the equipment used (<a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). </p> </section> <section id="CD009632-sec-0045"> <h5 class="title">Outcomes assessed</h5> <p>All studies analysed whether additional cancer cases were detected in women who had mammography screening in combination with ultrasonography compared to mammography screening alone. Five studies reported information about the proportion of interval cancers, the lymph node status of women with breast cancer, and the size of the detected cancers. Falseâpositive and falseânegative rates of the two screening methods were reported or could be calculated in four studies, and the number of required biopsies as a consequence of screening was reported in three studies. The followâup duration of the studies ranged from one to three years. </p> </section> </section> <section id="CD009632-sec-0046"> <h4 class="title">Excluded studies</h4> <p>We excluded 27 studies. The main reasons for exclusion were study populations that did not meet the eligibility criteria (e.g. women with high risk of breast cancer or women with negative mammography). Reasons for excluding studies after fullâtext review are summarised in <a href="./references#CD009632-sec-0105" title="">Characteristics of excluded studies</a>. </p> </section> </section> <section id="CD009632-sec-0047"> <h3 class="title">Risk of bias in included studies</h3> <p>Detailed risk of bias assessment data are available <a href="https://www.dropbox.com/sh/ej4elr5h3sh2bwx/AAANTr-KkcVb_ZS8prQjZ4Aka?dl=0" target="_blank">here</a>. </p> <section id="CD009632-sec-0048"> <h4 class="title">Risk of bias of randomised controlled trials</h4> <p>We assessed risk of bias for the included RCT with RoB 2 and presented the assessment of risk of bias for the endpoints studied. A risk of bias summary can be found in the correspondingÂ <a href="#CD009632-tbl-0004">Table 1</a>,Â <a href="#CD009632-fig-0003">Figure 3</a>. Â  </p> <div class="figure" id="CD009632-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias for JâSTART." data-id="CD009632-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias for JâSTART.</p> </div> </div> </div> <section id="CD009632-sec-0049"> <h5 class="title">OverallÂ </h5> <p>Overall, we rated the risk of bias (<a href="#CD009632-fig-0003">Figure 3</a>) for incremental cancer detection, incremental invasive cancer detection, interval cancer, lymph node status, size of cancers detected, falseâpositive rate, falseânegative rate, and biopsy rate inÂ <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>Â as low. The study was methodologically well conducted in most domains, and the likelihood of bias in the results was low (<a href="#CD009632-tbl-0004">Table 1</a>). Â  </p> <p> <ol id="CD009632-list-0005"> <li> <p><b>Bias arising from the randomisation process:</b> We judged risk of bias arising from the randomisation process as low for all outcomes assessed. InÂ <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, randomisation was performed centrally by an independent research unit. Allocation codes were kept in sealed envelopes and sent to the principal investigator. Baseline characteristics were similarly distributed between the two groups. </p> </li> <li> <p><b>Bias due to deviations from intended interventions:</b> We judged risk of bias due to deviations from intended interventions as some concerns for all outcomes assessed. Due to the nature of the two screening methods, it was not possible to mask participants and study coâordinators. To minimise bias, an independent panel unaware of the group assignment performed outcome assessment. Due to incomplete blinding, we rated the risk of bias due to deviations from intended interventions as moderate for all outcomes.Â  </p> </li> <li> <p><b>Bias due to missing outcome data:</b> We judged risk of bias due to missing outcome data as low for all outcomes assessed.<b>Â </b>During the course of the study, 0.4% of the initially 72,998 women dropped out at baseline or data were missing or unknown. The rates of dropouts and missing data were similar in both study groups. </p> </li> <li> <p><b>Bias due to measurement of outcomes:</b> We judged risk of bias due to measurement of outcomes as low for all reported results. According to our assessment, it is unlikely that the detection of the cancer cases (which is usually confirmed by biopsy) in the respective group was influenced by the incomplete blinding.Â  </p> </li> <li> <p><b>Bias due to selection of the reported results:</b> We judged risk of bias due to selection of the reported results as low. The reported endpoints were published in advance in a study protocol.Â  </p> </li> </ol> </p> </section> </section> <section id="CD009632-sec-0050"> <h4 class="title">Risk of bias of nonârandomised controlled trials</h4> <p>We assessed risk of bias for two prospective,Â <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>;Â <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>, and five retrospective cohort studies,Â <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>;Â <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>;Â <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>;Â <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>;Â <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>, using ROBINSâI (<a href="./references#CD009632-bbs2-0069" title="SterneJA , HernÃ¡nMA , ReevesBC , SavoviÄJ , BerkmanND , ViswanathanM , et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ2016;355:i4919.">Sterne 2016</a>). </p> <p>We have provided a risk of bias assessment for each outcome evaluated as per the tool. The summary and details can be found per outcome in the corresponding tables, as follows. </p> <p> <ul id="CD009632-list-0006"> <li> <p>Incremental cancer detection (<a href="#CD009632-tbl-0005">Table 2</a>) </p> </li> <li> <p>Incremental detection of invasive cancer (<a href="#CD009632-tbl-0006">Table 3</a>) </p> </li> <li> <p>Interval cancer (<a href="#CD009632-tbl-0007">Table 4</a>) </p> </li> <li> <p>Lymph node status (<a href="#CD009632-tbl-0008">Table 5</a>) </p> </li> <li> <p>Size of detected cancers (<a href="#CD009632-tbl-0009">Table 6</a>) </p> </li> <li> <p>Falseâpositive rate (<a href="#CD009632-tbl-0010">Table 7</a>) </p> </li> <li> <p>Falseânegative rate (<a href="#CD009632-tbl-0011">Table 8</a>) </p> </li> <li> <p>Rate of biopsies (<a href="#CD009632-tbl-0012">Table 9</a>) </p> </li> </ul> </p> <div class="table" id="CD009632-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: incremental cancer detection</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Starikov 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Asymptomatic women without a previous history of breast cancer were included, but no information about familial or genetic risk of breast cancer. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women received additional ultrasonography per specific radiologist's request.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography alone or in combination with tomosynthesis, 1/3 automated ABUS, 2/3 handheld ultrasonography </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Tohno 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No description of baseline characteristics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women who did choose an additional ultrasonography differed from women who were screened by mammography only. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <div class="table" id="CD009632-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: incremental detection of invasive cancer</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's</p> <p>request</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Starikov 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Asymptomatic women without a previous history of breast cancer were included, but no information about familial or genetic risk of breast cancer. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women received additional ultrasonography per specific radiologist's request.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography alone or in combination with tomosynthesis, 1/3 automated ABUS, 2/3 handheld ultrasonography </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <div class="table" id="CD009632-tbl-0007"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: interval cancers</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <div class="table" id="CD009632-tbl-0008"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: lymph node status</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For 15 cases of mammographically dectected cases, lymph node status was not available.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <div class="table" id="CD009632-tbl-0009"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 6.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: size of detected cancers</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <div class="table" id="CD009632-tbl-0010"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 7.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: falseâpositive rate</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Falseâpositive results of mammograpy only group not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <div class="table" id="CD009632-tbl-0011"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 8.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: falseânegative rate</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <div class="table" id="CD009632-tbl-0012"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 9.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: rate of biopsies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </div> <p>Overall, we rated the risk of bias for incremental cancer detection, incremental detection of invasive cancer, interval cancer, lymph node status, size of detected cancer, falseâpositive rate, falseânegative rate, and rate of biopsies as moderate to serious in most studies. We assessed the prospective study by Giuliano and colleagues as low risk for cancer detection and serious risk concerning falseâpositive results of breast cancer screening. The main reason for downgrading risk of bias was due to a lack of description of possible confounders, that confounding factors were not known for the whole population, or due to the selection of participants into the study which may have been influenced by suspicious findings or other prognostic factors. </p> <p> <ol id="CD009632-list-0007"> <li> <p><b>Bias due to confounding:</b> We rated the risk of bias due to confounding for the reported outcomes as low in two studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>,Â <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>), moderate in three studies (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>;Â <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>;Â <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>), and critical in two studies (<a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>;Â <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>). As the reported results could be influenced by prognostic factors in the respective groups, we classified the risk of bias due to confounding similarly for all endpoints depending on the study. Â In the study by Chough and colleagues and the study by Lee and colleagues, women participated in one or more rounds of screening (<a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>: not specified). In the study by Chough and colleagues, all the screenings were combined into a single number without differentiating whether one or two screening examinations took place. In the retrospective cohort study by Lee and colleagues, 3386 women who received 6081 screening examinations with mammography and sameâday ultrasonography were matched with 15,176 women who underwent 30,062 screening exams with mammography alone. Because of the lower preâtest probability of detecting cancer in the second round if the test result is negative after the first screening round, we classified the risk of bias due to confounding as moderate. In addition, in the study by Lee and colleagues, 13% of the screening examinations were performed on women who had a fiveâyear breast cancer risk of 2.5% to 3.99%, and 2% on women with a fiveâyear risk of 3.99% or higher. However, data on breast cancer risk were only available for 92% of the screening examinations. In the study by Starikov (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>), asymptomatic women without a previous history of breast cancer were included, but no information about familial or genetic risk of breast cancer was provided.Â  We considered bias due to confounding as critical for two retrospective studies (<a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>;Â <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>). Chae and colleagues did include asymptomatic women, but did not ascertain whether the women screened included women with a personal or family history of breast cancer or women with mutations in breast cancer genes, who may be more inclined to request additional ultrasonography. Tohno and colleagues included women who attended the institution for the purpose of breast cancer screening but did not describe any population inclusion criteria, so it remains unclear whether confounding factors were present that should have been considered. </p> </li> <li> <p><b>Bias in participant selection for the study:</b> We rated the risk of bias due to participant selection for the study for the reported outcomes as low in two prospective studies (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>;Â <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>), moderate in three retrospective studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>;Â <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>;Â <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>), and critical,Â <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>, or serious,Â <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>, in two retrospective studies. As the reported results could be influenced by the selective choice of participants into the respective groups, we classified the risk of bias similarly for all endpoints depending on the study. In two studies, supplemental ultrasonography was performed per specific request of a radiologist (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>;Â <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). In the largest retrospective study, all women with dense breasts received additional ultrasonography, and women with nonâdense breasts received additional ultrasonography based on a radiologist's referral (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>). Women with nonâdense breasts may have been preferentially referred for ultrasonography if mammography showed suspicious or unclear findings. In the retrospective study by Lee and colleagues, it was not verified for a large proportion of women whether screeningÂ was the indication for the additional ultrasonography examination (<a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). Data for the ultrasonography cohort were obtained from two registries, of which the screening indication was verified in one registry for 13.7% (728 of 5728) of the examinations. In the second registry, all data were checked and a screening indication for additional ultrasonography was confirmed for 77.9% of the reports. In the other two retrospective studies with a high risk of bias (<a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>;Â <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>), it remained unclear if women who did choose to undergo an additional ultrasonography differed from women who were screened by mammography only. </p> </li> <li> <p><b>Bias in classification of intervention:</b> We rated the risk of bias due to the classification of intervention for the reported outcomes as low in six of the sevenÂ cohort studies that described the examinations in the intervention and control groups.Â <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>Â did not provide any information on whether digital mammography was used, or which type of ultrasonography (ABUS, handheld ultrasound) was used. We therefore rated the risk of bias as moderate. </p> </li> <li> <p><b>Bias due to deviations from intended interventions:</b> No deviation from the predicted intervention was reported in any of the studies. We therefore rated the risk of bias as low for the reported outcomes. </p> </li> <li> <p><b>Bias due to missing data:</b> We rated the risk of bias due to missing data for the reported outcomes as moderate in two cohort studies,Â <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>;Â <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>, and as low for most of the outcomes in the five remaining cohort studies. For the outcome lymph node status, we rated the risk of bias due to missing data as serious inÂ <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>. In the study by Buchberger and colleagues, lymph node status was not available for 15 mammographically detected cases. In the prospective study by Chough and colleagues (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>), during the study period of up to three years with annual screenings, 14% of women did not get a second screening examination. As the occurrence of breast cancer is a rare event, cases could have been missed. InÂ <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>, the authors noted that patients may have chosen to be diagnosed and treated in another hospital, and that the cancer registry may have been incomplete.Â  </p> </li> <li> <p><b>Bias in measurement of outcomes:</b> As histopathology is the gold standard to identify breast cancer, it is unlikely that the breast cancer rate measurement was influenced by the knowledge of which screening intervention had been performed. We rated the risk of bias for this domain as low for all reported outcomes. In the study by Giuliano and colleagues, the pathologists were not aware of participant assignment and conducted their assessment in a blinded manner (<a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>). </p> </li> <li> <p><b>Bias in selection of the reported results:</b> In the prospective cohort study by Giuliano and colleagues (<a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>), no data were available on the falseâpositive rate of the group of women who underwent mammography alone.Â A request to the authors of the studies to add missing data has remained unanswered. We therefore rated the risk of bias due to selective reporting as critical for the outcome falseâpositive rate reported byÂ <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>. </p> </li> </ol> </p> </section> </section> <section id="CD009632-sec-0051"> <h3 class="title" id="CD009632-sec-0051">Effects of interventions</h3> <p>See: <a href="./full#CD009632-tbl-0001"><b>Summary of findings 1</b> Mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening in mixed populations of women with dense and nonâdense breasts</a>; <a href="./full#CD009632-tbl-0002"><b>Summary of findings 2</b> Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts</a>; <a href="./full#CD009632-tbl-0003"><b>Summary of findings 3</b> Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts</a> </p> <section id="CD009632-sec-0052"> <h4 class="title">Breast cancer mortality</h4> <p>No studies reported on breast cancer mortality.</p> </section> <section id="CD009632-sec-0053"> <h4 class="title">Allâcause mortality</h4> <p>No studies reported on allâcause mortality.</p> </section> <section id="CD009632-sec-0054"> <h4 class="title">Incremental cancer detection in mixed populations of women with dense and nonâdense breasts </h4> <p>In <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, two more breast cancers cases per 1000 women were detected in the group screened with a combination of mammography and ultrasonography compared with mammography alone (95% confidence interval (CI) 1 to 3 more). During a study period of one year, breast cancer was detected in five of 1000 women (184 of 36,752) screened by mammography and ultrasonography compared with three of 1000 women (117 of 35,965) screened by mammography alone (risk ratio (RR) 1.54, 95% CI 1.22 to 1.94; <a href="./references#CD009632-fig-0004" title="">Analysis 1.1</a>). The certainty of the evidence based on the result of the highâquality RCT was high (<a href="./full#CD009632-tbl-0001">summary of findings Table 1</a>). </p> <p>Consistent with the JâSTART, three cohort studies with a mixed population of women with dense and nonâdense breasts and a total of 88,972 participants showed higher detection rates for the combination of mammography and ultrasonography compared with mammography alone (<a href="./references#CD009632-fig-0004" title="">Analysis 1.1</a>.2) (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>; <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>). The pooled risk ratio of two retrospective cohort studies showed that breast cancer was detected in 0.42% (152 of 35,902) of women who received mammography and ultrasonography compared to 0.35% (167 of 47,567) in the mammography alone group (RR 1.35, 95% CI 0.92 to 1.98; I<sup>2</sup> = 32%) (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). This corresponds to one more cancer case detected per 1000 women (from 0 fewer to 3 more) with mammography screening and additional ultrasonography than with mammography alone. Adding the study of Tohno and colleagues, with a serious risk of bias, resulted in a similar risk ratio (RR 1.43, 95% CI 0.99 to 2.05; I<sup>2</sup> = 28%). However, due to the methodological limitations of cohort studies, we assessed the certainty of the evidence as low. </p> <p><a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a> studied women who participated in one or more rounds of screening and found no statistically significant difference in cancer detection between the two screening interventions (0.54% (33 of 6081) versus 0.55% (165 of 30,062); RR 0.99, 95% CI 0.68 to 1.44; <a href="./references#CD009632-fig-0004" title="">Analysis 1.1</a>.4). For the outcome incremental cancer detection rate, we classified the risk of bias as moderate for three of the cohort studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>), and serious for one cohort study (<a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>). </p> <section id="CD009632-sec-0055"> <h5 class="title">Incremental cancer detection in women with dense breasts</h5> <p>The secondary analysis of <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> with 11,390 women with dense breasts showed that the combination of mammography and ultrasonography detected three more breast cancer cases per 1000 women screened (95% CI from 0 fewer to 7 more) than mammography alone (0.71 versus 0.43%; RR 1.65, 95% CI 1.00 to 2.72). The certainty of evidence based on the result of the methodologically wellâconducted secondary analysis of the JâSTART study was high (<a href="./full#CD009632-tbl-0002">summary of findings Table 2</a>). </p> <p>Four cohort studies provided results of 71,191 women with dense breasts (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). We pooled the results of three cohort studies with a low or unclear risk of bias for key domains, specifically confounding bias and study participant selection (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). The metaâanalysis showed that amongst women with dense breasts, the combination of mammography and ultrasonography detected two more cancer cases (1 to 5 more) per 1000 screened women than mammography alone (0.45 versus 0.30%; RR 1.78, 95% CI 1.23 to 2.56; I<sup>2</sup> = 23%; <a href="./references#CD009632-fig-0011" title="">Analysis 2.1</a>.2). Adding the study of Chae and colleagues, rated as a high risk of bias (<a href="./references#CD009632-fig-0012" title="">Analysis 2.2</a>.1), resulted in a higher risk ratio and higher heterogeneity (RR 2.17, 95% CI 1.31 to 3.60; I<sup>2</sup> = 61%). It remains unclear whether the study population of Chae and colleagues included women with a personal or family history of breast cancer. The prospective cohort study by <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a> was presented separately, as women participated in one or two screening examinations, resulting in a lower preâtest probability of detecting cancer at the second screening round (<a href="./references#CD009632-fig-0012" title="">Analysis 2.2</a>.2). Due to methodological limitations, we assessed the certainty of the evidence of the pooled result of the three cohort studies as moderate (<a href="./full#CD009632-tbl-0002">summary of findings Table 2</a>). </p> </section> <section id="CD009632-sec-0056"> <h5 class="title">Incremental cancer detection in women with nonâdense breasts</h5> <p>Three studies provided data for 48,459 women with nonâdense breasts (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). Regarding cancer detection, the secondary analysis of JâSTART with data from 7823 women with nonâdense breasts showed that the combination of mammography and ultrasonography detected three more breast cancer cases per 1000 women screened (95% CI from 0 fewer to 10 more) than mammography alone (0.69 versus 0.36%; RR 1.93, 95% CI 1.01 to 3.68). Due to the imprecision of the result, we assessed the certainty of evidence for the result of the secondary analysis of the JâSTART for women with nonâdense breasts as moderate (<a href="./full#CD009632-tbl-0003">summary of findings Table 3</a>). </p> <p>In contrast to the JâSTART result, the two cohort studies of 40,636 women showed no statistically significant difference in detected cancer cases between the combination of mammography screening and ultrasonography and mammography alone (RR 1.13, 95% CI 0.85 to 1.49, I<sup>2</sup> = 0%; <a href="./references#CD009632-fig-0019" title="">Analysis 3.1</a>) (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). Due to methodological limitations, we assessed the certainty of the evidence of the pooled result of the two cohort studies as low (<a href="./full#CD009632-tbl-0003">summary of findings Table 3</a>). </p> </section> </section> <section id="CD009632-sec-0057"> <h4 class="title">Incremental detection of invasive cancer</h4> <p>Seven of the included studies reported the proportion of invasive cancer (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). In JâSTART, 71% of all tumours identified by screening were classified as invasive (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>). In the mammography in combination with ultrasonography group, 69.6% (128 of 184) of cancer cases were invasive compared to 73.5% (86 of 117) with mammography alone (RR 0.95, 95% CI 0.82 to 1.09). This corresponds to 37 fewer invasive cases per 1000 breast cancer cases (from 132 fewer to 66 more) detected by mammography and ultrasonography compared to mammography alone, with no statistically significant difference between the two screening methods. Due to imprecision, the certainty of the evidence is low that there was no statistically significant difference between the two screening interventions in terms of the proportion of invasive cases out of all cancer cases detected by screening. </p> <p>Consistent with the results of the JâSTART trial, a metaâanalysis of two cohort studies with a mixed population of women with dense and nonâdense breasts showed that the difference between the two screening interventions in terms of the proportion of invasive cases amongst screenâdetected cancers was not statistically significant (<a href="./references#CD009632-fig-0005" title="">Analysis 1.2</a>.2; <a href="./full#CD009632-tbl-0001">summary of findings Table 1</a>; <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). Due to the methodological limitations of cohort studies and the imprecise result, we assessed the certainty of evidence of the differences between the two screening methods in the detection of invasive cancer as very low. The study by Lee and colleagues, with one or more rounds of screening, found a lower rate of invasive cancer in women screened with mammography and ultrasound compared to mammography alone, but the difference did not reach statistical significance (<a href="./references#CD009632-fig-0005" title="">Analysis 1.2</a>.3). </p> <p>In the secondary analysis of <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, the proportion of invasive cancer amongst screenâdetected cancer cases of women with dense breasts was 70.8% (46 of 65), whereas 61.0% (25 of 41) of cancer cases amongst women with nonâdense breasts were invasive, with no statistically significant difference between the two screening interventions (<a href="./references#CD009632-fig-0013" title="">Analysis 2.3</a>.1; <a href="./references#CD009632-fig-0020" title="">Analysis 3.2</a>). </p> <p>Three cohort studies were exclusively performed in women with dense breasts (<a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>). In the prospective study by Giuliano and colleagues, all women had dense breasts and all detected cancer cases were invasive (<a href="./references#CD009632-fig-0013" title="">Analysis 2.3</a>.2). We assessed the results of <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a> as at serious risk of bias; these are presented in <a href="./references#CD009632-fig-0013" title="">Analysis 2.3</a>.3. Women in the prospective study by <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a> participated in one to two screening rounds; the results are presented in <a href="./references#CD009632-fig-0013" title="">Analysis 2.3</a>.4. </p> </section> <section id="CD009632-sec-0058"> <h4 class="title">Interval cancer</h4> <p>Five studies reported the proportion of interval cancer cases (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). In JâSTART, 0.05% (18 of 36,752) of interval cancers occurred in the group screened by mammography in combination with ultrasonography, compared with 0.10% (35 of 35,965) in the group screened by mammography alone (P = 0.034; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>). Eightyânine per cent (16 of 18) of all interval cancers in the group receiving mammography and additional ultrasonography were invasive compared to 77% (27 of 35) in the group receiving mammography alone (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>). The certainty of the evidence based on the result of the highâquality RCT was high. In the largest retrospective study (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>), screening with a combination of mammography and ultrasonography was performed in all women whose data were evaluated in the study. In a total of 66,680 women, 28 interval cancers occurred (0.04%). In the second largest retrospective cohort study by Lee and colleagues, with one or more screening rounds and 36,143 exams in 18,562 women, fewer interval cancer cases occurred in the mammography plus ultrasonography group, with no statistically significant difference between the two screening methods (<a href="./references#CD009632-fig-0006" title="">Analysis 1.3</a>.2). In the group of women who received mammography in combination with ultrasonography, 1.5 interval cancer cases per 1000 screening examinations were reported, compared to 1.9 in the group with mammography alone (RR 0.67, 95% CI 0.33 to 1.37). Due to the methodological limitations of cohort studies, we assessed the certainty of the evidence as low. </p> <p>In the secondary analysis of the JâSTART (HaradaâShoji 2021), which examined data from women with dense and nonâdense breasts separately, the proportion of interval cancers was lower when mammographic screening was performed in combination with ultrasonography compared to the group that received only mammographic screening, regardless of breast density (<a href="./references#CD009632-fig-0014" title="">Analysis 2.4</a>.1; <a href="./references#CD009632-fig-0021" title="">Analysis 3.3</a>). In women with dense breasts, one fewer per 1000 (from 2 to 0 fewer) interval cancer cases occurred in the group screened with mammography and ultrasonography than in group with mammography alone (0.1% (3 of 5797) versus 0.2% (10 of 5593); RR 0.29, 95% CI 0.08 to 1.05). </p> <p>In the <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a> study, in which women participated in one to two screening rounds, no interval cancer cases occurred. <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>, with a serious risk of bias, reported no interval cancer cases in women with dense breasts screened by mammography and ultrasonography, and five cases in the mammography only group (<a href="./references#CD009632-fig-0014" title="">Analysis 2.4</a>.2; 0% (0 of 8359) versus 0.04% (5 of 12,505); RR 0.14, 95% CI 0.01 to 2.46). </p> </section> <section id="CD009632-sec-0059"> <h4 class="title">Lymph node status in women with screenâdetected breast cancer</h4> <p>The proportion of women with cancer and a positive lymph node status varied in five studies, ranging from 0 to 25% (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> reported that a numerically higher proportion of women with invasive cancer that had been detected by mammography only had a positive lymph node status. Amongst women with invasive cancer that had been detected with mammography screening in combination with ultrasonography, 18% (23 of 128) had a positive lymph node status, compared to 34% (29 of 86) detected by mammography alone (RR 0.53, 95% CI 0.33 to 0.86; <a href="./references#CD009632-fig-0007" title="">Analysis 1.4</a>.1). Due to the imprecise result, we assessed the certainty of the evidence as moderate. </p> <p>No statistically significant differences in the proportion of women with positive lymph nodes amongst screenâdetected cancers were found between the two screening interventions in the cohort studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). Due to the methodological limitations of cohort studies and the imprecise result, we assessed the certainty of evidence regarding the lymph node status of women with screenâdetected cancer as very low. In the retrospective study by Lee and colleagues (<a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>), with one or more screening rounds, the proportions of women with breast cancer (nonâinvasive and invasive) who had positive lymph nodes were similar: 14.6% (6 of 41) versus 16.4% (36 of 219; RR 0.89, 95% CI 0.40 to 1.98; <a href="./references#CD009632-fig-0007" title="">Analysis 1.4</a>.3). In the study by Buchberger, lymph node status was not available for 15 mammographically detected cases. The proportion of women with positive lymph nodes amongst identified cancer cases is presented in <a href="./references#CD009632-fig-0007" title="">Analysis 1.4</a>.2. We assessed risk of bias for the outcome as serious. </p> <p>Separate data for women with dense and nonâdense breasts are presented in <a href="./references#CD009632-fig-0015" title="">Analysis 2.5</a> and <a href="./references#CD009632-fig-0022" title="">Analysis 3.4</a>, respectively. These data include a few cases with positive lymph nodes. The lowest proportions of invasive cancer cases with positive lymph node status were reported in two prospective studies. Giuliano and colleagues reported that 2% (1 of 42) of women with breast cancer screened by mammography and ultrasonography had positive lymph nodes compared to 5% (1 of 19) in the mammography only group. In the study by Chough and colleagues, women with dense breasts underwent one to two screening rounds, with all cancer cases (8 of 598) being nodeânegative. </p> </section> <section id="CD009632-sec-0060"> <h4 class="title">Size of detected cancers</h4> <p>Five studies reported tumour sizes (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). In <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, the mean size of 128 invasive tumours was 15.3 mm (standard deviation (SD) 12.6) in the group screened by mammography and additional ultrasonography compared to 15.1 mm (SD 8.7) of 86 invasive tumours in the mammography alone group (mean difference 0.2, 95% CI â2.65 to 3.05). </p> <p>All but one prospective cohort study, <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>, showed that tumour sizes were comparable irrespective of whether screening was done with mammography and ultrasonography or with mammography alone (<a href="#CD009632-tbl-0013">Table 10</a>). </p> <div class="table" id="CD009632-tbl-0013"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 10.</span>Â <span class="table-title">Size of detected cancers across studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mammography + ultrasonography</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mammography</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mean difference, P value</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>JâSTART 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 15.3 mm (SD 12.6) in 128 invasive tumours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 15.1 mm (SD 8.7) in 86 invasive tumours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.2, 95% CI â2.65 to 3.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 14 mm (range: 3 to 32 mm, 25% percentile: 10 mm, 75% percentile: 16 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 14 mm (range: 1 to 41 mm, 25% percentile: 10 mm, 75% percentile: 20 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.63</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4 to 1.2 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.8. to 1.2 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 14.3 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 21.3 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â¤ 20 mm: 13 of 20 (65%)<br/>&gt; 20 mm: 7 of 20 (35%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â¤ 20 mm: 96 of 140 (68.6%)<br/>&gt; 20 mm: 44 of 140 (31.4%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not available</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; MD: mean difference; SD: standard deviation</p> </div> </div> <p>In the prospective study by Giuliano and colleagues (<a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>), the invasive tumours detected by mammography had a mean size of 21.3 mm, whilst the size of the tumours in the group with additional ultrasound was smaller, measuring 14.3 mm on average (SD not available, no P value). The majority of cancer cases in the group with additional ultrasonography were stage Ia tumours (83%: 35 of 42). </p> </section> <section id="CD009632-sec-0061"> <h4 class="title">Healthârelated quality of life</h4> <p>No studies reported on healthârelated quality of life in the respective screening intervention and control groups. </p> </section> <section id="CD009632-sec-0062"> <h4 class="title">Falseâpositive rate in mixed populations of women with dense and nonâdense breasts</h4> <p>Falseâpositive rates in mixed populations could be calculated or were provided in three studies (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> and two retrospective studies, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a> and <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). </p> <p><a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> reported a higher proportion of falseâpositive results in women screened by mammography and additional ultrasonography than in women screened by mammography alone. Amongst women with no cancer who underwent mammography screening with additional ultrasonography examination, the proportion of falseâpositive results was 12.3% (4427 of 35,847) compared with 8.6% (3015 of 34,978) with mammography screening alone (RR 1.43, 95% CI 1.37 to 1.50). The certainty of the evidence based on the result of the highâquality RCT was high. </p> <p>The two retrospective cohort studies reported higher falseâpositive rates amongst women screened with mammography and ultrasonography than with mammography alone. Due to the methodological limitations of cohort studies and heterogeneous results, we assessed the certainty of evidence regarding falseâpositive rates of the two screening methods based on the results of the cohort studies as very low. The largest retrospective study, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>, showed a lower proportion of falseâpositive results than <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, though the proportion of detected cancer cases was lower. In the study by Buchberger and colleagues, women who were invited annually or biannually received mammography screening in combination with ultrasonography. About 19 per 1000 women had an intermediate mammogram at six months. It can be assumed that the intermediate mammograms at 6 months were used to calculate the specificity of screening at 12 months followâup because the specificity was much higher (calculated: 96.0% to 98.7%) than in <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> (87.8% to 91.4%). Amongst women who were screened by mammography and ultrasonography, the proportion of falseâpositives was 3.0% (1959 of 66,382) compared to 2.7% (1760 of 66,382) with mammography alone (RR 1.11, 95% CI 1.04 to 1.19; <a href="./references#CD009632-fig-0008" title="">Analysis 1.5</a>.2). </p> <p>Consistent with the results of <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, the second largest retrospective study by <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a> reported that the risk of receiving a falseâpositive result was 2.2 times higher with screening by mammography in combination with ultrasonography when compared to women who received mammography screening alone (52.0 versus 22.2 per 1000 screens; RR 2.23, 95% CI 1.93 to 2.58). The falseâpositive rate when the two screening methods were applied is presented in <a href="./references#CD009632-fig-0008" title="">Analysis 1.5</a>.3. </p> <section id="CD009632-sec-0063"> <h5 class="title">Falseâpositive rate in women with dense and nonâdense breasts</h5> <p>Calculations based on numerical data from the secondary analysis of the <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> showed that in women with dense breasts who had no cancer, the risk of receiving a falseâpositive result was 1.76 times higher (14.6% versus 8.3%; RR 1.76, 95% CI 1.58 to 1.96) in the mammography in combination with ultrasonography group compared to mammography screening alone (<a href="./references#CD009632-fig-0016" title="">Analysis 2.6</a>). In women with nonâdense breasts, the risk of receiving a falseâpositive result was 1.36 times higher (11.0% versus 8.1%; RR 1.36, 95% CI 1.18 to 1.56; <a href="./references#CD009632-fig-0023" title="">Analysis 3.5</a>). The certainty of the evidence based on the result of the highâquality RCT was high. </p> <p>Two cohort studies found higher falseâpositive rates in women with dense breasts screened with mammography and ultrasound than with mammography alone (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>). Due to the hetereogenous results, risk of bias, and methodological limitations of cohort studies, we assessed the certainty of evidence of differences between the two screening methods in terms of the rate of falseâpositive results in women with dense breasts to be very low. In the largest retrospective study by <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>, amongst women with dense breasts who were screened by mammography and ultrasonography, the proportion of falseâpositives was 2.1% (666 of 31,822), compared to 1.2% (385 of 31,822) with mammography alone (<a href="./references#CD009632-fig-0016" title="">Analysis 2.6</a>.2). As previously mentioned, falseâpositive rates in the retrospective cohort study by Buchberger were lower than in the RCT because intermediate mammograms may have been included in the calculation of specificity. The retrospective study by Chae and colleagues, with a serious risk of bias, also reported higher falseâpositive rates amongst women with dense breasts who were screened with combined mammography and ultrasonography than with mammography alone (5.2% (432 out of 8335) versus 4.1% (517 out of 12,494). The prospective study by Giuliano and colleagues only reported the falseâpositive results of mammography screening in combination with ultrasonography, finding that 0.3% (10 out of 3334 women with no cancer) had a positive test result but no cancer (<a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>). </p> <p>In women with nonâdense breasts, the largest retrospective cohort study, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>, showed that the proportion of falseâpositive results was similar between the two screening methods (3.7% (1293 of 34,560) versus 4.0% (1375 of 34,560); <a href="./references#CD009632-fig-0023" title="">Analysis 3.5</a>.2). In the study by Buchberger and colleagues, women with nonâdense breasts were referred at the specific request of a radiologist, therefore in women with nonâdense breasts, suspicious or unclear mammography results or other factors could have led to additional ultrasonography being performed. </p> </section> </section> <section id="CD009632-sec-0064"> <h4 class="title">Falseânegative rate in mixed populations of women with dense and nonâdense breasts</h4> <p>Falseânegative rates in mixed populations could be calculated or were provided in three studies (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> and two retrospective studies, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a> and <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). JâSTART and the largest retrospective study by Buchberger showed a lower risk of falseânegative results in women who underwent mammography screening in combination with ultrasonography. In <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, 202 women in the group screened with a combination of mammography and ultrasonography had cancer, of which 8.9% (18 of 202) were not detected by screening and were classified as falseânegatives. Amongst women with cancer who underwent mammography screening, 23% (35 of 152) were misclassified as not having cancer (RR 0.39, 95% CI 0.23 to 0.66). Due to the width of the confidence interval, the certainty of evidence based on the result of the JâSTART was moderate (<a href="./full#CD009632-tbl-0001">summary of findings Table 1</a>). Consistent with the JâSTART study, a similar proportion of falseânegatives amongst screenâdetected cancers was observed in women undergoing mammography screening in combination with ultrasound or mammography alone in the study by Buchberger and colleagues (9.4% (28 out of 298) compared to 21.5% (64 out of 298); RR 0.44, 95% CI 0.29 to 0.66; <a href="./references#CD009632-fig-0009" title="">Analysis 1.6</a>). The retrospective study by <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>, in which women participated in one or more screening rounds, reported no statistically significant difference between the two screening methods (1.5 versus 1.9 per 1000 screenings; RR 0.67, 95% CI 0.33 to 1.37). The percentage of the falseânegative rate when the two screening methods were applied is presented in <a href="./references#CD009632-fig-0009" title="">Analysis 1.6</a>. Due to the methodological limitations and the inconsistent results, we assessed the certainty of evidence based on the cohort study by Lee and colleagues showing no statistically significant difference between the two screening methods in terms of the proportion of falseânegative results in women with cancer to be very low. </p> </section> <section id="CD009632-sec-0065"> <h4 class="title">Falseânegative rate in women with dense and nonâdense breasts</h4> <p><a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> and the largest study, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>, analysed women with dense and nonâdense breasts separately. <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a> only considered women with dense breasts. </p> <p>A secondary analysis of a subpopulation of the JâSTART study showed that women with and without dense breasts had a similarly higher risk of a falseânegative result when examined with mammography alone (<a href="./references#CD009632-fig-0017" title="">Analysis 2.7</a>.1; <a href="./references#CD009632-fig-0024" title="">Analysis 3.6</a>.1). In <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, 44 women with dense breasts in the group screened with a combination of mammography and ultrasonography had cancer of which 6.8% (3 of 44) were not detected by screening and were classified as falseânegatives. Amongst women with dense breasts who had cancer and underwent mammography screening alone, 29.4% (10 of 34) were misclassified as not having cancer (RR 0.23, 95% CI 0.07 to 0.78). Due to the width of the confidence interval, the certainty of evidence based on the result of the JâSTART was moderate (<a href="./full#CD009632-tbl-0002">summary of findings Table 2</a>). Consistent with JâSTART, in the two cohort studies, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>, with a total of 131 women with dense breasts who had cancer, the risk of falseânegative results was lower with the combination of mammography and ultrasonography compared with mammography screening alone (<a href="./references#CD009632-fig-0017" title="">Analysis 2.7</a>.2). </p> <p>Similarly, <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> showed that the risk of falseânegative results amongst women with nonâdense breasts who had cancer was lower in the group screened with a combination of mammography and ultrasonography than in women who underwent mammography screening (6.9% (2 of 29) versus 39.1% (9 out of 23) were misclassified as not having cancer; RR 0.18, 95% CI 0.04 to 0.74; <a href="./references#CD009632-fig-0024" title="">Analysis 3.6</a>.1). Due to the width of the confidence interval, the certainty of evidence based on the results of the JâSTART was moderate (<a href="./full#CD009632-tbl-0003">summary of findings Table 3</a>). Data from the study by Buchberger and colleagues also showed that falseânegative rates in women with nonâdense breasts who had cancer were lower with the combination of mammography and ultrasonography than with mammography alone (5.0% (10 out of 202) versus 13.4% (27 out of 202)). </p> <p>Due to the methodological limitations and the heterogeneous results, we assessed the certainty of evidence based on the results of the cohort studies as very low. </p> </section> <section id="CD009632-sec-0066"> <h4 class="title">Rate of biopsies</h4> <p>The JâSTART and two retrospective studies reported the proportion of biopsies in both groups (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). Analogous to the rate of falseâpositive results, the proportion of biopsies rate was higher in women who were screened with mammography in combination with ultrasonography compared to mammography alone. In <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, 4.5% (1665 of 36,752) of women who received mammography screening and additional ultrasonography underwent a biopsy, compared to 1.8% (655 of 35,965) with mammography only (RR 2.49, 95% CI 2.28 to 2.72). The certainty of the evidence based on the results of the highâquality RCT was high. </p> <p>Consistent with this result, both retrospective studies found that the risk of a biopsy after screening was higher when an additional ultrasound was performed. In the retrospective study by Lee and colleagues (<a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>), the proportion of biopsies was 57.4 per 1000 screens in the combined mammography and ultrasonography group versus 27.7 per 1000 screens in the mammography only group (RR 2.05, 95% CI 1.79 to 2.34; <a href="./references#CD009632-fig-0010" title="">Analysis 1.7</a>.3). In the study by Lee and colleagues, 15% of the screenings were done on women who had a fiveâyear breast cancer risk of 2.5% or greater. In the retrospective study by Buchberger and colleagues (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>), biopsy rates were lower than in the JâSTART and in the study by Lee and colleagues (mammography plus ultrasonography: 0.9% (623 of 66,680) versus mammography alone: 0.6% (422 of 66,680); <a href="./references#CD009632-fig-0010" title="">Analysis 1.7</a>.2). As mentioned above under 'Falseâpositive rate in mixed populations of women with dense and nonâdense breasts', it can be assumed that intermediate mammograms at 6 months were used to calculate the specificity of screening at 12 months followâup, which could have contributed to the lower biopsy rate at 12 months followâup. Due to the heterogeneous results and methodological limitations of the cohort studies, we assessed the certainty of evidence regarding biopsy rates in women screened with mammography in combination with ultrasonography or with mammography alone based on the results of the cohort studies as very low. </p> <p><a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> and <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a> provided separate data for women with dense and nonâdense breasts, showing that for both populations the risk of biopsy was higher with a combination of mammography and ultrasound than with mammography alone (<a href="./references#CD009632-fig-0018" title="">Analysis 2.8</a>; <a href="./references#CD009632-fig-0025" title="">Analysis 3.7</a>). </p> </section> <section id="CD009632-sec-0067"> <h4 class="title">Screeningâassociated harm</h4> <p>The JâSTART study reported that no complications or adverse events related to mammography and ultrasonography occurred during the entire screening period. None of the other studies reported on screeningâassociated harm such as psychological distress, adverse effects caused by subsequent diagnostic or therapeutic interventions, or other adverse events. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD009632-sec-0068" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD009632-sec-0068"></div> <section id="CD009632-sec-0069"> <h3 class="title" id="CD009632-sec-0069">Summary of main results</h3> <p>We found one RCT, <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, with data from 72,717 women, that analysed the efficacy of mammography screening in combination with ultrasonography compared to mammography screening alone. A recent secondary analysis, HaradaâShoji 2021, of the same RCT with a subpopulation of 19,213 women provided separate results for women with dense and nonâdense breasts. In addition, we identified two prospective studies, <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>, and five retrospective cohort studies, <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>; <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>, that were relevant to our review. The results of <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a> and the majority of the cohort studies showed that screening with a combination of mammography and ultrasonography detected more breast cancer cases than mammography alone. In <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>, which represents the best available evidence, two more breast cancer cases (from 1 to 3 more) per 1000 women were detected with combined mammography and ultrasonography compared to mammography alone after a single screening round (0.50% versus 0.32%). The JâSTART study included 57.7% women with dense breasts. Similarly, the secondary analysis of the JâSTART, HaradaâShoji 2021, showed that in women with dense breasts, mammography and ultrasonography detected more breast cancer cases compared to mammography alone. The pooled results of three cohort studies supported this finding and revealed that more cancer cases were detected with the combination of mammography and ultrasonography than with mammography screening alone (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). The certainty of the evidence was high, such that in women with dense breasts, more cancer cases were detected by mammography screening in combination with ultrasonography compared with mammography alone. </p> <p>Data from the secondary analysis of the JâSTART, HaradaâShoji 2021, revealed that in women with dense breasts, the risk of receiving a falseâpositive result was about two times higher with screening by mammography in combination with ultrasonography compared to mammography alone (14.6% versus 8.3%). The proportion of falseâpositive results was slightly lower in women with nonâdense breasts (11.0% versus 8.1%). However, due to the imprecision of the result, we assessed the evidence for the benefit of additional ultrasonography for cancer detection in women with nonâdense breasts to be of moderate certainty. Evidence from realâworld data did not confirm this finding: low certainty evidence from two cohort studies found no statistically significant difference between the two screening methods in women with nonâdense breasts (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). In the overall JâSTART population of 72,717 women, the effect of additional cancer detection was less with additional ultrasonography than in the dense and nonâdense breast subpopulations by themselves. It appears that more data provide more accurate results, especially in women with nonâdense breasts. </p> </section> <section id="CD009632-sec-0070"> <h3 class="title" id="CD009632-sec-0070">Overall completeness and applicability of evidence</h3> <p>Our systematic review includes one RCT and seven cohort studies that assessed the comparative efficacy of mammography in combination with ultrasonography compared to mammography alone. All studies analysed whether additional cancer cases were detected in women who had mammography screening in combination with ultrasonographyÂ compared to mammography screening alone. Six studies provided information about cancer detection in women with dense breasts, and three studies in women with nonâdense breasts. Five studies reported interval cancer cases, the lymph node status of women with breast cancer who were detected by screening, and the size of the detected cancers. Three studies provided information on falseâpositive and falseânegative rates and the number of required biopsies.Â However,Â the screening methods used in the studies only partially met the requirements of the European guidelines for quality assurance in breast cancer screening and diagnosisÂ (<a href="./references#CD009632-bbs2-0050" title="Organising breast cancer screening programmes. https://healthcare-quality.jrc.ec.europa.eu/european-breast-cancer-guidelines/organisation-of-screening-programme#recs-group-1 8 November 2022.">European Commission 2022</a>). For example, the European Commission recommends double reading in mammography screening for early detection of breast cancer, with consensus when expert findings disagree. Mammography was assessed independently by two reviewers in four studies (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>;Â <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>;Â <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>;Â <a href="./references#CD009632-bbs2-0008" title="TohnoE , UmemotoT , SasakiK , MorishimaI , UenoE . Effect of adding screening ultrasonography to screening mammography on patient recall and cancer detection rates: a retrospective study in Japan. European Journal of Radiology2013;82(8):1227-30. ">Tohno 2013</a>), and ultrasonography was also assessed by double reading in three of these four studies (<a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>;Â <a href="./references#CD009632-bbs2-0004" title="GiulianoV , GiulianoC . Improved breast cancer detection in asymptomatic women using 3D-automated breastultrasound in mammographically dense breasts. Clinical Imaging2013;37(3):480-6. ">Giuliano 2013</a>;Â <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>). In the largest retrospective cohort study,Â <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>, and in Starikov's retrospective study,Â <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>, mammography and ultrasound were assessed by one reviewer. Two studies lacked detailed information on the evaluation process of mammography and ultrasonography (<a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a>;Â <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>).Â <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>Â did report that the technologists and physicians involved in the trial completed a twoâday course about screening process standards. Only oneÂ study provided any information about the number of screening examinations per year, which is one of the criteria to ensure accurate diagnosis based on breast imaging (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>). The US Food and Drug Administration (FDA) requires evaluating physicians to have performed at least 960 mammographic exams in the 24 months prior to the facility's annual Mammography Quality Standards Act (MQSA) inspection (<a href="./references#CD009632-bbs2-0072" title="Compliance guidance: the Mammography Quality Standards Act Final Regulations: preparing for MQSA inspections; final. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/compliance-guidance-mammography-quality-standards-act-final-regulations-preparing-mqsa-inspections 20 August 2018.">US FDAÂ </a>). Five of the eight included studies examined a large number of women per study site. The RCT examined more than 72,000 women from 42 study centres, corresponding to an average of more than 1700 mammograms per year per study centre. (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>).Â <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>Â analysed 36,143 screening exams performed in 18,562 women for the matched analysis, but did not specify the number of study sites at which these examinations were conducted. The smallest study,Â <a href="./references#CD009632-bbs2-0003" title="ChoughDM , BergWA , BandosAI , RathfonGY , HakimCM , LuAH , et al. A prospective study of automated breast ultrasound screening of women with dense breasts in a digital breast tomosynthesis-based practice. Journal of Breast Imaging2020;2(2):125-33. ">Chough 2020</a>, examined 598 women, and it remains unclear whether the study site met quality requirements. </p> <p>The RCT differs in several respects from the cohort studies, which may more closely match the realâworld setting. The RCT considered women between 40 and 49 years of age, 23% of whom had never had a mammogram, whereas the retrospective study by Buchberger and colleagues included more than 50% women 50 to 69 years of age. The US Preventive Services Task Force currently recommends biennial mammography screening for women aged 50 to 74 years (<a href="./references#CD009632-bbs2-0067" title="SiuAL . Screening for Breast Cancer: U.S. Preventive Services Task Force Recommendation Statement. Annals of Internal Medicine2016;164(4):279-96.">Siu 2016</a>), which covers the age groups analysed in the cohort studies. Further, a higher percentage of women from Asian populations were found to have dense breasts compared to other populations (<a href="./references#CD009632-bbs2-0054" title="HellerSL , HudsonS , WilkinsonLS . Breast density across a regional screening population: effects of age, ethnicity and deprivation. The British Journal of Radiology2015;88(1055):20150242.">Heller 2015</a>); however, the results of the JâSTART study consisted solely of Japanese women and may not be generalisable to other populations. InÂ <a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>, the proportion of cancer cases in women with dense breasts was lower (2.4 per 1000 women) than in the secondary analysis ofÂ <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>Â (6.8 per 1000 women). One reason for the different proportions of cancer cases that were detected in the JâSTART study versus the largest retrospective cohort study by Buchberger and colleagues can be attributed to the fact that fewer new cases were detected in subsequent rounds of screening amongst women in the retrospective study who had already been screened several times due to the higher age range. In addition, the retrospective study most likely used intermediate mammograms (performed in 19 of 1000 women screened) to calculate the sensitivity and specificity of mammography and ultrasonography. </p> <p>In the real world, biopsies may be performed more frequently than in an RCT. For example, in the JâSTART study, 4.5% of women who received screening mammography and additional ultrasonography underwent a biopsy, compared to 1.8% who received mammography alone. In the retrospective study by Lee and colleagues, the biopsy rate was higher. Biopsies were performed in 57.4 of 1000 women in the group that received mammography and ultrasonography, compared with 27.7 of 1000 women in the group that received mammography alone. One reason for this may be that up to 15% of the screening examinations were performed in women who had a higher fiveâyear breast cancer risk in the study by Lee and colleagues, which may reflect routine daily clinical practice, since not all participants in screening programmes are comprehensively screened for risk factors in advance. </p> </section> <section id="CD009632-sec-0071"> <h3 class="title" id="CD009632-sec-0071">Quality of the evidence</h3> <p>For the assessment of the certainty of evidence, we primarily relied on the results of the JâSTART trial (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; HaradaâShoji 2021), which represents the best available evidence and was rated as having a low risk of bias. For the majority of the results based on the JâSTART total population numbers, we rated the certainty of the evidence as high or moderate due to the precision of the results. No statistically significant difference was found between the two screening methods in the proportion of invasive cancer amongst screenâdetected cancer cases, but the certainty of the evidence was rated low due to imprecision. Based on the secondary analysis of the JâSTART, we rated the certainty of evidence as high, finding that in women with dense breasts, more cancers cases are detected by mammography screening in combination with ultrasonography compared with mammography alone. Regarding women with nonâdense breasts, we rated the certainty of evidence as moderate, finding that more cancers cases are detected by mammography screening in combination with ultrasonography compared with mammography alone. The confidence interval of the absolute risk reduction was not sufficiently narrow to achieve a high degree of certainty. The results of the cohort studies were described in relation to JâSTART, which was methodologically very well performed. </p> <p>We assessed the certainty of the evidence from the cohort studies as very low to moderate due to methodological limitations and heterogeneous or imprecise results. The population may differ in terms of breast cancer risk, as not all the retrospective studies adequately described the characteristics of the population, or there may have been specific reasons why women were assigned to additional ultrasonography. For example, <a href="./references#CD009632-bbs2-0002" title="ChaeEY , KimHH , ChaJH , ShinHJ , KimH . Evaluation of screening whole-breast sonography as a supplemental tool in conjunction with mammography in women with dense breasts. Journal of Ultrasound in Medicine2013;32(9):1573-8. ">Chae 2013</a> lacked data on the percentage of women with a personal history of breast cancer or whose firstâdegree relatives had breast cancer. In two retrospective studies, the selection of women into the study who received ultrasonography in addition to mammography screening may have been influenced by suspicious findings or other factors, as they were referred by physicians (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). Nevertheless, in women with dense breasts, the direction of the effect in the cohort studies was consistent with <a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>. In women with nonâdense breasts, results concerning cancer detection rates in the cohort studies could not confirm the benefit of additional ultrasonography in mammography screening. </p> </section> <section id="CD009632-sec-0072"> <h3 class="title" id="CD009632-sec-0072">Potential biases in the review process</h3> <p>Publication bias is a threat for any systematic review. Although we conducted extensive searches of grey literature in our first search, we cannot be sure that we found every study conducted in this field. For the latest update search, we assessed the contribution of databases and other resources previously used for the retrieval of relevant studies. Concerning grey literature, only study registers had information about potentially relevant unpublished or ongoing studies. For this reason, we limited the update search to the following grey literature sources: WHO ICTRP and ClinicalTrials.gov. </p> <p>In cases of incomplete or unclear data, we contacted the study authors. Only one author of the RCT answered our questions. Previously unpublished data were published whilst we were finalising our review (HaradaâShoji 2021). </p> <p>Due to the small number of studies on the comparative effectiveness and safety of mammography screening in combination with breast ultrasonography versus mammography alone in women at average risk of breast cancer, the validity of statistical methods to explore publication bias, such as funnel plots, was limited. </p> </section> <section id="CD009632-sec-0073"> <h3 class="title" id="CD009632-sec-0073">Agreements and disagreements with other studies or reviews</h3> <p>This is the first systematic review and metaâanalysis assessing the effect of mammography screening in combination with ultrasonography compared to mammography alone with separate metaâanalyses for women with dense and nonâdense breasts. </p> <p>Breast density refers to the proportion of glandular tissue in the breast, and ranges from a high proportion of fatty tissue to very dense breasts consisting mostly of glandular tissue. In a Danish cohort study, the sensitivity of digital mammography decreased from 78% in BIâRADSâ1 (Breast Imaging Reporting and Data System) to 47% in women with BIâRADSâ4 (<a href="./references#CD009632-bbs2-0059" title="LyngeE , VejborgI , AndersenZ , vonEuler-ChelpinM , NapolitanoG . Mammographic density and screening sensitivity, breast cancer incidence and associated risk factors in Danish breast cancer screening. Journal of Clinical Medicine2019;8(11):1.">Lynge 2019</a>). A recent systematic review considering women with dense breasts and an initially negative mammography showed that additional ultrasonography screening results in a higher sensitivity (96%) at the expense of a lower specificity (88%) (<a href="./references#CD009632-bbs2-0076" title="YuanWH , HsuHC , ChenYY , WuCH . Supplemental breast cancer-screening ultrasonography in women with dense breasts: a systematic review and meta-analysis. British Journal of Cancer2020;123(4):673-88.">Yuan 2020</a>). However, the question is whether breast density is the only criterion to consider when deciding to perform additional imaging. According to a large cohort study (<a href="./references#CD009632-bbs2-0058" title="KerlikowskeK , ZhuW , TostesonAN , SpragueBL , TiceJA , LehmanCD , et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Annals of Internal Medicine2015;162(10):673-81.">Kerlikowske 2015</a>), high interval cancer rates were observed in women with extremely dense breasts and a fiveâyear risk of developing breast cancer of 1.67% or greater, and in women with heterogeneously dense breasts and a fiveâyear risk of 2.49% or greater (BCSCâ5âyear risk: Breast Cancer Surveillance Consortium Risk Calculator). For the majority of women, including those with dense breasts and low risk of breast cancer, who underwent digital mammography, the rate of interval cancer was low. Women with heterogeneously or extremely dense breasts and lowâtoâaverage risk of breast cancer had interval cancer rates between 0.58 and 0.89 per 1000 mammograms. A riskâbased approach to identify women with dense breasts at high risk for interval cancer may reduce falseâpositive results (<a href="./references#CD009632-bbs2-0058" title="KerlikowskeK , ZhuW , TostesonAN , SpragueBL , TiceJA , LehmanCD , et al. Identifying women with dense breasts at high risk for interval cancer: a cohort study. Annals of Internal Medicine2015;162(10):673-81.">Kerlikowske 2015</a>). </p> <p>None of the included studies reported on whether breast cancer screening with mammography and additional ultrasound resulted in a reduced mortality rate. This may be because the observation period was too short to compare death rates or disease progression between the two groups. Simply diagnosing more cases of illness does not necessarily result in lower mortality or less morbidity. A recently published study showed that for every 10,000 women aged 40 years who received annual mammography screening for 23 years, mortality was reduced by five cases compared with no screening (0.34% (182 of 53,883) versus 0.39% (412 of 106,953)) (<a href="./references#CD009632-bbs2-0045" title="DuffyS , VulkanD , CuckleH , ParmarD , SheikhS , SmithR , et al. Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT. Health Technology Assessment2020;24(55):1-24.">Duffy 2020</a>). However, the reduction in mortality must be weighed against the harms, such as overdiagnosis, which is considered one of the greatest harms of breast screening. Estimations of overdiagnosis in mammography screening vary depending on the analytic approach of the modelling studies, and range from 11% to 22% (<a href="./references#CD009632-bbs2-0064" title="NelsonHD , PappasM , CantorA , GriffinJ , DaegesM , HumphreyL , US Preventive Services Task Force. Harms of Breast Cancer Screening: Systematic Review to Update the 2009 U.S. Preventive Services Task Force Recommendation. Annals of Internal Medicine2016;164(4):256-67.">Nelson 2016b</a>). An analysis of the Surveillance, Epidemiology, and End Results (SEER) database looked at the influence of mammography screening on the incidence of small breast cancer tumours with a size of 19 mm or below (<a href="./references#CD009632-bbs2-0075" title="WelchG , ProrokP , O'MalleyJ , KramerB . Breast-cancer tumor size, overdiagnosis and mammography screening effectiveness. The New England Journal of Medicine2016;375:1438-47.">Welch 2016</a>). The results showed that the incidence of smallâsized tumours dramatically increased from 82 per 100,000 women (1975 to 1979) before widespread mammography screening was implemented to 244 per 100,000 in the period 2008 to 2012, whilst larger tumours decreased from 145 to 115 per 100,000 women. The authors assumed that some of the larger tumours were detected earlier by screening, and that the increase of the smallâsized tumours that occurred after the implementation of widespread mammography screening were often overdiagnosed breast tumours, which might not have caused any problems during a woman's lifetime. Taking into account that treatment of breast cancer has improved in the last few decades, the authors calculated that mammography screening reduces the mortality rate by eight deaths per 100,000 women. The studies included in our review also showed similar tumour sizes: in the JâSTART study, the average size of breast cancer detected by screening was 15 mm, and in the retrospective study by Lee and colleagues, 2/3 of the tumours were 20 mm or less (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>; <a href="./references#CD009632-bbs2-0006" title="LeeJM , AraoRF , SpragueBL , KerlikowskeK , LehmanCD , SmithRA , et al. Performance of screening ultrasonography as an adjunct to screening mammography in women across the spectrum of breast cancer risk. JAMA Internal Medicine2019;179(5):658-67. ">Lee 2019</a>). From a healthcare perspective, weighing benefits against harms is crucial when recommending screening tests. Whether the net effect of screening is harmful or beneficial depends on whether the tumour develops indolently or aggressively, the prevalence in the population, and whether extensive treatment can be avoided by early detection (<a href="./references#CD009632-bbs2-0048" title="EssermanLJ , ThompsonIM , ReidB , NelsonP , RansohoffDF , WelchHG , et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. The Lancet Oncology2014;15(6):e234-42.">Esserman 2014</a>). Fastâgrowing, aggressive tumours are more often detected not by screening but more commonly between screening exams. The National Comprehensive Cancer Network recommends regular screening or to discuss preventive mastectomy as an option for women with BRCAâ1 or BRCAâ2 mutations (Grade 2 A; <a href="./references#CD009632-bbs2-0044" title="DalyMB , PalT , BerryMP , BuysSS , DicksonP , DomchekSM , et al. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network2021;19(1):77-102.">Daly 2021</a>). </p> <p>In the case of indolent tumours, which grow very slowly, do not grow at all, or even regress and would not cause any symptoms throughout life, early detection leads to more harm than good (<a href="./references#CD009632-bbs2-0048" title="EssermanLJ , ThompsonIM , ReidB , NelsonP , RansohoffDF , WelchHG , et al. Addressing overdiagnosis and overtreatment in cancer: a prescription for change. The Lancet Oncology2014;15(6):e234-42.">Esserman 2014</a>). The proportion of indolent tumours detected by breast cancer screening is unclear. Before the introduction of widespread breast cancer screening, ductal carcinoma in situ (DCIS) was rarely diagnosed (<a href="./references#CD009632-bbs2-0073" title="vanSeijenM , LipsEH , ThompsonAM , Nik-ZainalS , FutrealA , HwangES , et al. Ductal carcinoma in situ: to treat or not to treat, that is the question. British Journal of Cancer2019;121(4):285-92.">van Seijen 2019</a>). DCIS cases account for 25% of all breast cancers detected, and 75% can be detected due to calcifications on mammography, whilst 25% are mammographically occult. DCIS is classified as preâ or nonâinvasive and is usually treated with breastâconserving surgery or mastectomy and additional radiotherapy, and in some cases with endocrine therapy. The treatment of DCIS lesions is associated with side effects such as considerable psychological distress, reduced quality of life, and complications of the surgical procedure, although a large proportion of these lesions are unlikely to develop into invasive cancer. To determine whether some people with DCIS are being overtreated, three RCTs are currently underway comparing active surveillance with standard treatment in lowârisk DCIS patients (<a href="./references#CD009632-bbs2-0046" title="ElshofLE , TryfonidisK , SlaetsL , vanLeeuwen-StokAE , SkinnerVP , DifN , et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study. European Journal of Cancer2015;51(12):1497-510.">Elshof 2015</a>; <a href="./references#CD009632-bbs2-0051" title="FrancisA , ThomasJ , FallowfieldL , WallisM , BartlettJM , BrookesC , et al. Addressing overtreatment of screen detected DCIS; the LORIS trial. European Journal of Cancer2015;51(16):2296-303.">Francis 2015</a>; <a href="./references#CD009632-bbs2-0057" title="Hwang ES , HyslopT , LynchT , FrankE , PintoD , BasilaD , et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open2019;9(3):e026797.">Hwang 2019</a>). In the JâSTART trial, 28% (84 of 301) of cancers detected by screening were nonâinvasive and included DCIS and lobular carcinomas (<a href="./references#CD009632-bbs2-0005" title="Harada-ShojiN , SuzukiA , IshidaT , Zheng Y-F, Narikawa-ShionoY , Sato-tadanoA , et al. Evaluation of adjunctive ultrasonography for breast cancer detection among women aged 40-49 years with varying breast density undergoing screening mammography: a secondary analysis of a randomized clinical trial. JAMA Network Open2021;4(8):e2121505. OhuchiN , IshidaT , KawaiM , NarikawaY , YamamotoS , SobueT . Randomized controlled trial on effectiveness of ultrasonography screening for breast cancer in women aged 40-49 (J-START): research design. Japanese Journal of Clinical Oncology2011;41(2):275-7. OhuchiN , SuzukiA , SobueT , KawaiM , YamamotoS , ZhengYF , et al, J-START investigator groups. Sensitivity and specificity of mammography and adjunctive ultrasonography to screen for breast cancer in the Japan Strategic Anti-cancer Randomized Trial (J-START): a randomised controlled trial. Lancet2016;387(10016):341-8. ">JâSTART</a>). But even amongst invasive tumours, there has been an increase since the introduction of screening, especially in those with less aggressive characteristics. It is estimated that 20% of all invasive breast cancers represent overdiagnosed cancer cases (<a href="./references#CD009632-bbs2-0040" title="BleyerA , WelchHG . Effect of three decades of screening mammography on breast-cancer incidence. The New England Journal of Medicine2012;367(21):1998-2005.">Bleyer 2012</a>). The challenge therefore remains to determine which women might benefit from screening and which women do not need screening. The topic for further research is riskâbased screening to identify women who do not benefit or benefit very little from screening, and in whom harm predominates. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD009632-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Analytic pathway of the comparative efficacy and risk of harms of mammography screening with and without supplemental ultrasonography." data-id="CD009632-fig-0001" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-01.jpg"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Analytic pathway of the comparative efficacy and risk of harms of mammography screening with and without supplemental ultrasonography. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-01.jpg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD009632-fig-0002" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias for JâSTART." data-id="CD009632-fig-0003" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-03.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias for JâSTART.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-FIG-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 1: Incremental cancer detection" data-id="CD009632-fig-0004" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 1: Incremental cancer detection </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 2: Incremental detection of invasive cancers" data-id="CD009632-fig-0005" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 2: Incremental detection of invasive cancers </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 3: Interval cancers" data-id="CD009632-fig-0006" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 3: Interval cancers </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 4: Lymph node status in women with screenâdetected breast cancer" data-id="CD009632-fig-0007" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 4: Lymph node status in women with screenâdetected breast cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 5: Falseâpositive rate: proportion of falseâpositive results amongst women with no cancer" data-id="CD009632-fig-0008" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 5: Falseâpositive rate: proportion of falseâpositive results amongst women with no cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 6: Falseânegative rate: proportion of falseânegative results amongst women with cancer" data-id="CD009632-fig-0009" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 6: Falseânegative rate: proportion of falseânegative results amongst women with cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 7: Rate of biopsies" data-id="CD009632-fig-0010" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts, Outcome 7: Rate of biopsies </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 1: Incremental cancer detection rate in women with dense breasts" data-id="CD009632-fig-0011" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 1: Incremental cancer detection rate in women with dense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 2: Incremental cancer detection rate in women with dense breasts: cohort studies with a serious risk of bias or one or more screening rounds" data-id="CD009632-fig-0012" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 2: Incremental cancer detection rate in women with dense breasts: cohort studies with a serious risk of bias or one or more screening rounds </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 3: Incremental detection of invasive cancers in women with dense breasts" data-id="CD009632-fig-0013" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 3: Incremental detection of invasive cancers in women with dense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 4: Interval cancer in women with dense breasts" data-id="CD009632-fig-0014" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 4: Interval cancer in women with dense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 5: Lymph node status in women with screenâdetected breast cancer" data-id="CD009632-fig-0015" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 5: Lymph node status in women with screenâdetected breast cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 6: Falseâpositive rate in women with dense breasts: proportion of falseâpositive results amongst women with no cancer" data-id="CD009632-fig-0016" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 6: Falseâpositive rate in women with dense breasts: proportion of falseâpositive results amongst women with no cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 7: Falseânegative rate in women with dense breasts: proportion of falseânegative results amongst women with cancer" data-id="CD009632-fig-0017" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 7: Falseânegative rate in women with dense breasts: proportion of falseânegative results amongst women with cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 8: Biopsy rate in women with dense breasts" data-id="CD009632-fig-0018" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts, Outcome 8: Biopsy rate in women with dense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 1: Incremental cancer detection rate for women with nonâdense breasts" data-id="CD009632-fig-0019" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 1: Incremental cancer detection rate for women with nonâdense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 2: Incremental detection of invasive cancers in women with nonâdense breasts" data-id="CD009632-fig-0020" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 2: Incremental detection of invasive cancers in women with nonâdense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 3: Interval cancer in women with nonâdense breasts" data-id="CD009632-fig-0021" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 3: Interval cancer in women with nonâdense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 4: Lymph node status in women with screenâdetected breast cancer" data-id="CD009632-fig-0022" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 4: Lymph node status in women with screenâdetected breast cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 5: Falseâpositive rate in women with nonâdense breasts: proportion of falseâpositive results amongst women with no cancer" data-id="CD009632-fig-0023" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 5: Falseâpositive rate in women with nonâdense breasts: proportion of falseâpositive results amongst women with no cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 6: Falseânegative rate in women with nonâdense breasts: proportion of falseânegative results amongst women with cancer" data-id="CD009632-fig-0024" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 6: Falseânegative rate in women with nonâdense breasts: proportion of falseânegative results amongst women with cancer </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD009632-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/urn:x-wiley:14651858:media:CD009632:CD009632-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 7: Biopsy rate in women with nonâdense breasts" data-id="CD009632-fig-0025" src="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_t/tCD009632-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts, Outcome 7: Biopsy rate in women with nonâdense breasts </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/media/CDSR/CD009632/image_n/nCD009632-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD009632-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening in mixed populations of women with dense and nonâdense breasts</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Mammography + ultrasound compared to mammography alone for breast cancer screening in mixed populations of women with dense and nonâdense breasts</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> breast cancer screeningÂ in women with dense and nonâdense breasts<br/><b>Setting:Â </b> screening<br/><b>Intervention:</b> mammography + ultrasoundÂ <br/><b>Comparison:</b> mammography alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes after 1â to 2âyear followâup</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with mammography alone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk difference with mammography + ultrasound</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Breast cancer mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Insufficient </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>NR</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Allâcause mortality</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>ââââ<br/>Insufficient </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>NR</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>NR</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>72,717<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.54<br/>(1.22 to 1.94) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 more per 1000<br/>(1 to 3 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>83,469</p> <p>(2 cohort studies)</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.35 (0.92 to 1.98)</p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 more per 1000<br/>(0 to 3 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental detection of invasive cancers: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>301<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.95<br/>(0.82 to 1.09) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of invasive cases out of all cancer cases detected by screening</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>74 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 fewer per 100<br/>(13 fewer to 7 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental detection of invasive cancers: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>571<br/>(2 cohort studies) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Very low <sup>1,3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.00<br/>(0.95 to 1.06) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of invasive cases out of all cancer cases detected by screening</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0 fewer per 100<br/>(4 fewer to 5 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Interval cancer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>72,717<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.50<br/>(0.29 to 0.89) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>10 per 10,000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 fewer per 10,000<br/>(7 fewer to 1 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lymph node status</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>214<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.53<br/>(0.33 to 0.86) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of positive lymph node staus among invasive cancer cases</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>34 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>16 fewer per 100<br/>(23 to 5 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseâpositive rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>70,825<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.43<br/>(1.37 to 1.50) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseâpositive results amongst women with no cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>86 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>37 more per 1000<br/>(32 more to 43 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseânegative rate</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>354<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.39<br/>(0.23 to 0.66) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseânegative results amongst women with cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 fewer per 100<br/>(8 to 18 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Rate of biopsies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>72,717<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.49<br/>(2.28 to 2.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>27 more per 1000<br/>(23 more to 31 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).Â <br/><b>CI:</b> confidence interval; <b>NR:</b> not reported; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to risk of bias in the two retrospective cohort studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>): in both studies, additional ultrasonography was performed at the explicit request of a radiologist. In the study by Buchberger and colleagues, women with nonâdense breasts were specifically allocated to receive additional ultrasonography. In one of the two studies, no information was provided on familial or genetic breast cancer risk (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>).<br/><sup>2</sup>Result not statistically significant, downgraded due to imprecision.<br/><sup>3</sup>Downgraded due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone for breast cancer screening in mixed populations of women with dense and nonâdense breasts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009632-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Mammography + ultrasound compared to mammography alone for breast cancer screening (dense breasts)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> breast cancer screening in women at average risk with dense breasts </p> <p><b>Setting:</b> screening<br/><b>Intervention:</b> mammography + ultrasound<br/><b>Comparison:</b> mammography alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes after 1â to 2âyear followâup</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with mammography alone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk difference with mammography + ultrasound</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection in women with dense breasts: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,390<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.65<br/>(1.0 to 2.72) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 more per 1000<br/>(0 fewer to 7 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection in women with dense breasts: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>50,327<br/>(3 cohort studies) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.78<br/>(1.23 to 2.56) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 more per 1000<br/>(1 more to 5 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental detection of invasive cancers</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>65<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.91<br/>(0.67 to 1.24) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of invasive cases out of all cancer cases detected by screening</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>68 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 fewer per 100<br/>(23 fewer to 16 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Interval cancer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,390<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.29<br/>(0.08 to 1.05) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 fewer per 1000<br/>(2 to 0 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseâpositive rate in women with dense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,312<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.76<br/>(1.58 to 1.96) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseâpositive results amongst women with no cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>63 more per 1000<br/>(48 more to 80 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseânegative rate in women with dense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>78<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>3</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.23<br/>(0.07 to 0.78) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseânegative results amongst women with cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 fewer per 100<br/>(7 to 27 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Biopsy rate in women with dense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>11,390<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.73<br/>(2.24 to 3.34) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>23 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39 more per 1000<br/>(28 more to 53 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). </p> <p><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to risk of bias in one of the three retrospective cohort studies (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>): additional ultrasonography was performed at the explicit request of a radiologist. No information was provided on familial or genetic breast cancer risk. <br/><sup>2</sup>Result not statistically significant, downgraded due to imprecision.<br/><sup>3</sup>Downgraded due to imprecision. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD009632-tbl-0003"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Mammography + ultrasound compared to mammography alone for breast cancer screening (nonâdense breasts)</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign="top"> <p><b>Patient or population:</b> breast cancer screening (nonâdense breasts) <br/><b>Setting:</b> screening<br/><b>Intervention:</b> mammography + ultrasound <br/><b>Comparison:</b> mammography alone </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes after 1â to 2âyear followâup</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>â of participants<br/>(studies)</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk with mammography alone</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Risk difference with mammography + ultrasound</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection for women with nonâdense breasts: RCT</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7823<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.93<br/>(1.01 to 3.68) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 more per 1000<br/>(0 fewer to 10 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Incremental cancer detection for women with nonâdense breasts: cohort studies</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>40,636<br/>(2 cohort studies) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Low <sup>2</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.13<br/>(0.85 to 1.49) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>4 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 more per 1000<br/>(1 fewer to 2 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Interval cancer</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7823<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.22<br/>(0.05 to 1.03) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 fewer per 1000<br/>(0 to 2 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseâpositive rate in women with nonâdense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7771<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.36<br/>(1.18 to 1.56) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseâpositive results amongst women with no cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>29 more per 1000<br/>(15 to 45 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Falseânegative rate in women with nonâdense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>52<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>Moderate <sup>1</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.18<br/>(0.04 to 0.74) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Proportion of falseânegative results amongst women with cancer</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>39 per 100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>32 fewer per 100<br/>(10 to 38 fewer) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Biopsy rate in women with nonâdense breasts</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>7823<br/>(1 RCT) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="2" valign="top"> <p>ââââ<br/>High </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.58<br/>(1.96 to 3.40) </p> </td> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>18 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>28 more per 1000<br/>(17 to 42 more) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI). <br/><b>CI:</b> confidence interval; <b>RCT:</b> randomised controlled trial; <b>RR:</b> risk ratio </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="6" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect.<br/><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different.<br/><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect.<br/><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>1</sup>Downgraded due to imprecision: absolute risk reduction with wide confidence interval.<br/><sup>2</sup>Downgraded due to risk of bias in the two retrospective cohort studies (<a href="./references#CD009632-bbs2-0001" title="BuchbergerW , Geiger-GritschS , KnappR , GautschK , OberaignerW . Combined screening with mammography and ultrasound in a population-based screening program. European Journal of Radiology2018;101:24-9. ">Buchberger 2018</a>; <a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>): in both studies, additional ultrasonography was performed at the explicit request of a radiologist. In the study by Buchberger and colleagues, women with nonâdense breasts were specifically allocated to receive additional ultrasonography. In one of the two studies, no information was provided on familial or genetic breast cancer risk (<a href="./references#CD009632-bbs2-0007" title="StarikovA , DrotmanM , HentelK , KatzenJ , MinRJ , ArleoEK . 2D mammography, digital breast tomosynthesis, and ultrasound: which should be used for the different breast densities in breast cancer screening?Clinical Imaging2016;40(1):68-71. ">Starikov 2016</a>). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 3.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0004"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Risk of bias for randomised controlled trial (JâSTART): all outcomes</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias arising from the randomisation process</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to missing outcome data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Bias due to selection of the reported result</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incremental cancer detection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incremental detection of invasive cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Interval cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lymph node status</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Falseânegative rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Falseâpositive rate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Rate of biopsies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Some concerns</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Justification</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Randomisation was performed centrally by an independent research unit. Allocation codes were kept in sealed envelopes and sent to the principal investigator. Baseline characteristics were similarly distributed between the two groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Incomplete blinding: because of the nature of the two screening methods, it was not possible to mask participants and study coâordinators. To minimise bias, an independent panel unaware of the group assignment performed outcome assessment. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>During the course of the study, 0.4% of the initially 72,998 women dropped out at baseline, or data were missing or unknown. The rate of dropouts and missing data was similar in both study groups. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>It is unlikely that the detection of cancer cases, usually confirmed by biopsy, in the respective group was influenced by incomplete blinding. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The reported endpoints were published in advance in a study protocol.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span>Â <span class="table-title">Risk of bias for randomised controlled trial (JâSTART): all outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0005"> <div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: incremental cancer detection</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Starikov 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Asymptomatic women without a previous history of breast cancer were included, but no information about familial or genetic risk of breast cancer. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women received additional ultrasonography per specific radiologist's request.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography alone or in combination with tomosynthesis, 1/3 automated ABUS, 2/3 handheld ultrasonography </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Tohno 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No description of baseline characteristics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women who did choose an additional ultrasonography differed from women who were screened by mammography only. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: incremental cancer detection</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0006"> <div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: incremental detection of invasive cancer</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's</p> <p>request</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Starikov 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Asymptomatic women without a previous history of breast cancer were included, but no information about familial or genetic risk of breast cancer. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women received additional ultrasonography per specific radiologist's request.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography alone or in combination with tomosynthesis, 1/3 automated ABUS, 2/3 handheld ultrasonography </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: incremental detection of invasive cancer</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0007"> <div class="table-heading"><span class="table-label">Table 4.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: interval cancers</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: interval cancers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0008"> <div class="table-heading"><span class="table-label">Table 5.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: lymph node status</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>For 15 cases of mammographically dectected cases, lymph node status was not available.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: lymph node status</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0009"> <div class="table-heading"><span class="table-label">Table 6.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: size of detected cancers</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Two rounds of screening, results were presented as the results of a screening round with twice as many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital breast tomosynthesis, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14% of women did not get a second screening examination.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 6.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: size of detected cancers</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0010"> <div class="table-heading"><span class="table-label">Table 7.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: falseâpositive rate</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with dense breasts with no family history of breast cancer or positive BRCA gene </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ABUS</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Falseâpositive results of mammograpy only group not reported.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 7.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: falseâpositive rate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0011"> <div class="table-heading"><span class="table-label">Table 8.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: falseânegative rate</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Chae 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Serious</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Potentially included: women with a personal or family history of breast cancer or mutations in breast cancer genes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with a family history of breast cancer or who are more health conscious may be more inclined to undergo additional sonography (voluntary selfâfinanced). </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Diagnosis and treatment possibly at another hospital, data collection could be incomplete</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 8.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: falseânegative rate</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0012"> <div class="table-heading"><span class="table-label">Table 9.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: rate of biopsies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Confounding</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Participant selection</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Classification of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Deviations from intended interventions</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Missing data</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Measurement of outcomes</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Selection of the reported results</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Overall</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excluded: women with personal or firstâdegree family history</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Women with nonâdense breasts received additional ultrasonography per specific radiologist's request. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Digital mammography, ultrasonography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Analysis of retrospective data: no deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Moderate</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>One to two rounds of screening or more (not specified),</p> <p>data on breast cancer risk were incomplete, it remains unclear whether screening was the indication for the additional ultrasonography for many women </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No evidence of bias due to selection of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No information was provided on whether digital mammography was used or which type of ultrasonography (ABUS, handheld ultrasound) was used. </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication for deviations from intended interventions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>All women analysed.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>The biopsy results are unlikely to be biased.</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No indication of selective reporting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>ABUS: automated breast ultrasound</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 9.</span>Â <span class="table-title">Risk of bias for nonârandomised studies: rate of biopsies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD009632-tbl-0013"> <div class="table-heading"><span class="table-label">Table 10.</span>Â <span class="table-title">Size of detected cancers across studies</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mammography + ultrasonography</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mammography</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Mean difference, P value</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>JâSTART 2016</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 15.3 mm (SD 12.6) in 128 invasive tumours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 15.1 mm (SD 8.7) in 86 invasive tumours</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>MD 0.2, 95% CI â2.65 to 3.05</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Buchberger 2018</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 14 mm (range: 3 to 32 mm, 25% percentile: 10 mm, 75% percentile: 16 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Median: 14 mm (range: 1 to 41 mm, 25% percentile: 10 mm, 75% percentile: 20 mm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>P = 0.63</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Chough 2020</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.4 to 1.2 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.8. to 1.2 cm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Giuliano 2013</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 14.3 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mean: 21.3 mm</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not available</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lee 2019</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â¤ 20 mm: 13 of 20 (65%)<br/>&gt; 20 mm: 7 of 20 (35%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>â¤ 20 mm: 96 of 140 (68.6%)<br/>&gt; 20 mm: 44 of 140 (31.4%) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Not available</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="4"> <div class="table-footnote"> <p>CI: confidence interval; MD: mean difference; SD: standard deviation</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 10.</span>Â <span class="table-title">Size of detected cancers across studies</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/full#CD009632-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009632-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Incremental cancer detection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.54 [1.22, 1.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83469</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.35 [0.92, 1.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Cohort study with a serious risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5503</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.32 [0.80, 6.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Cohort study with one or more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>36143</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.68, 1.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Incremental detection of invasive cancers <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>301</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.82, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>571</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.95, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Cohort study with one or more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>263</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.59, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 Interval cancers <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3.2 Cohort study with one or more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 Lymph node status in women with screenâdetected breast cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.2 Cohort study with a serious risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4.3 Cohort study with one ore more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 Falseâpositive rate: proportion of falseâpositive results amongst women with no cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.5.3 Cohort study with one or more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 Falseânegative rate: proportion of falseânegative results amongst women with cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.2 Cohort study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.6.3 Cohort study with one or more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 Rate of biopsies <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.7.3 Cohort study with one or more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in mixed populations of women with dense and nonâdense breasts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009632-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Incremental cancer detection rate in women with dense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>61717</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.73 [1.33, 2.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>11390</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.65 [1.00, 2.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50327</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.78 [1.23, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Incremental cancer detection rate in women with dense breasts: cohort studies with a serious risk of bias or one or more screening rounds <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Cohort study with a serious risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Cohort study with one or more screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Incremental detection of invasive cancers in women with dense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Cohort study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.3 Cohort study with a serious risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.4 Cohort study with one to two screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Interval cancer in women with dense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Cohort study with a serious risk of bias</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Lymph node status in women with screenâdetected breast cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.2 Cohort study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.3 Cohort study with one to two screening rounds</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Falseâpositive rate in women with dense breasts: proportion of falseâpositive results amongst women with no cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 Falseânegative rate in women with dense breasts: proportion of falseânegative results amongst women with cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.7.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 Biopsy rate in women with dense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.8.2 Cohort study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with dense breasts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD009632-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 3.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Incremental cancer detection rate for women with nonâdense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48459</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.32 [0.92, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7823</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.93 [1.01, 3.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.2 Cohort studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.85, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Incremental detection of invasive cancers in women with nonâdense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 Interval cancer in women with nonâdense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 Lymph node status in women with screenâdetected breast cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 Falseâpositive rate in women with nonâdense breasts: proportion of falseâpositive results amongst women with no cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 Cohort study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 Falseânegative rate in women with nonâdense breasts: proportion of falseânegative results amongst women with cancer <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.2 Cohort study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 Biopsy rate in women with nonâdense breasts <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.1 RCT: JâSTART</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.7.2 Cohort study</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (MâH, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Totals not selected</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span>Â <span class="table-title">Mammography in combination with breast ultrasonography versus mammography alone in women with nonâdense breasts</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD009632.pub3/references#CD009632-tbl-0016">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD009632.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD009632-note-0015">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD009632-note-0024">EspaÃ±ol</a> </li> <li class="section-language"> <a class="" href="fa#CD009632-note-0020">ÙØ§Ø±Ø³Û</a> </li> <li class="section-language"> <a class="" href="fr#CD009632-note-0022">FranÃ§ais</a> </li> <li class="section-language"> <a class="" href="id#CD009632-note-0021">Bahasa Indonesia</a> </li> <li class="section-language"> <a class="" href="ms#CD009632-note-0019">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD009632-note-0023">Polski</a> </li> <li class="section-language"> <a class="" href="ru#CD009632-note-0017">Ð ÑÑÑÐºÐ¸Ð¹</a> </li> <li class="section-language"> <a class="" href="th#CD009632-note-0018">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD009632-note-0016">ç¹é«ä¸­æ</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright Â© 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">Â Â Facebook</a> <a class="a2a_button_x share-button">Â Â X(Twitter)</a> <a class="a2a_button_whatsapp share-button">Â Â WhatsApp</a> <a class="a2a_dd share-button">Â Â View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009632\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009632\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009632\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD009632\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD009632\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=77cjsSG8&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009632.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD009632.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">EspaÃ±ol</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">ÙØ§Ø±Ø³Û</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">FranÃ§ais</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">à¤¹à¤¿à¤¨à¥à¤¦à¥</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">æ¥æ¬èª</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">íêµ­ì´</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">PortuguÃªs</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Ð ÑÑÑÐºÐ¸Ð¹</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">RomÃ¢nÄ</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">à®¤à®®à®¿à®´à¯</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">à¸ à¸²à¸©à¸²à¹à¸à¸¢</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">ç¹é«ä¸­æ</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">ç®ä½ä¸­æ</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD009632.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD009632.pub3/full/es">EspaÃ±ol</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD009632.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740718456956"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009632.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740718456960"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD009632.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918dd0cc7eccf401',t:'MTc0MDcxODQ1Ny4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 